ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BCSAU Blockchain Coinvestors Acquisition Corporation I

11.56
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Blockchain Coinvestors Acquisition Corporation I NASDAQ:BCSAU NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.56 9.38 11.48 0 00:00:00

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14/11/2023 9:01pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                to                

 

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-41050   98-1607883

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

PO Box 1093, Boundary Hall

Cricket Square, Grand Cayman

KY1-1102, Cayman Islands

(Address Of Principal Executive Offices)

 

(345) 814-5726

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant   BCSAU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   BCSA   The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   BCSAW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☐

 

As of November 14, 2023, 13,433,794 Class A ordinary shares, par value $0.0001 per share, and 0 Class B ordinary shares, par value $0.00009 per share, were issued and outstanding.

 

 

 

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

Form 10-Q

For the Quarter Ended September 30, 2023

 

Table of Contents

 

    Page
PART I. FINANCIAL INFORMATION  
Item 1. Condensed Consolidated Financial Statements 1
  Condensed Consolidated Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 1
  Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 2
  Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2023 and 2022 3
  Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
Item 4. Controls and Procedures 28
PART II. OTHER INFORMATION  
Item 1. Legal Proceedings 29
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
Item 3. Defaults Upon Senior Securities 29
Item 4. Mine Safety Disclosures 29
Item 5. Other Information 29
Item 6. Exhibits 29

 

i

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Condensed consolidated financial Statements

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,
2023
   December 31,
2022
 
   (Unaudited)     
Assets:        
Current assets:        
Cash  $222,456   $254,781 
Prepaid expenses   63,224    384,630 
Total current assets   285,680    639,411 
Investments held in Trust Account   39,041,590    310,263,214 
Total Assets  $39,327,270   $310,902,625 
           
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit:          
Current liabilities:          
Accounts payable  $4,944,332   $3,704,441 
Convertible promissory note – related party, fair value   525,824    525,824 
Convertible promissory note – related party, par value   1,241,420    
 
Accrued expenses   328,294    320,516 
Total current liabilities   7,039,870    4,550,781 
Derivative liabilities   1,052,424    1,581,227 
Deferred underwriting commissions in connection with the initial public offering   11,280,000    11,280,000 
Total Liabilities   19,372,294    17,412,008 
Commitments and Contingencies   
 
    
 
 
Class A ordinary shares subject to possible redemption; $0.0001 par value; 3,593,271 and 30,000,000 shares at redemption value of approximately $10.84 and $10.34 per share as of September 30, 2023 and December 31, 2022, respectively   38,941,590    310,163,214 
Shareholders’ Deficit:          
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022   
    
 
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,322,000 shares issued and outstanding (excluding 3,593,271 and 30,000,000 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively   132    132 
Class B ordinary shares, $0.00009 par value; 50,000,000 shares authorized; 10,000,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022   900    900 
Additional paid-in capital   
    
 
Accumulated deficit   (18,987,646)   (16,673,629)
Total shareholders’ deficit   (18,986,614)   (16,672,597)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit  $39,327,270   $310,902,625 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
General and administrative expenses  $355,310   $1,174,367   $2,735,330   $3,088,036 
General and administrative expenses - related party   28,671    45,000    107,490    135,000 
Loss from operations   (383,981)   (1,219,367)   (2,842,820)   (3,223,036)
                     
Other income:                    
Change in fair value of derivative liabilities   189,498    117,457    255,274    9,827,277 
Change in fair value of forward purchase agreement   127,957    
    273,529    
 
Income earned on investments held in Trust Account   502,059    1,533,315    2,986,102    1,679,514 
Total Other income   819,514    1,650,772    3,514,905    11,506,791 
                     
Net income  $435,533   $431,405   $672,085   $8,283,755 
Weighted average number of shares outstanding of Class A ordinary shares, basic and diluted
   4,915,271    31,322,000    8,784,389    31,322,000 
Basic and diluted net income per share, Class A ordinary shares
  $0.03   $0.01   $0.04   $0.20 
Weighted average number of shares outstanding of Class B ordinary shares, basic and diluted
   10,000,000    10,000,000    10,000,000    10,000,000 
Basic and diluted net income per share, Class B ordinary shares
  $0.03   $0.01   $0.04   $0.20 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

 

   Ordinary Shares   Additional       Total 
   Class A   Class B   Paid-in   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance - December 31, 2022   1,322,000   $132    10,000,000   $900   $
   $(16,673,629)  $(16,672,597)
Shareholder non-redemption agreements       
        
    155,250    
    155,250 
Shareholder non-redemption agreements       
        
    (155,250)   
    (155,250)
Increase in redemption value of Class A ordinary shares subject to possible redemption       
        
    
    (2,028,239)   (2,028,239)
Net loss       
        
    
    (479,264)   (479,264)
Balance - March 31, 2023 (unaudited)   1,322,000    132    10,000,000    900    
    (19,181,132)   (19,180,100)
Increase in redemption value of Class A ordinary shares subject to possible redemption       
        
    
    (455,804)   (455,804)
Net income       
        
    
    715,816    715,816 
Balance – June 30, 2023 (unaudited)   1,322,000   132    10,000,000   900    
   (18,921,120)  (18,920,088)
Increase in redemption value of Class A ordinary shares subject to possible redemption       
        
    
    (502,059)   (502,059)
Net income       
        
    
    435,533    435,533 
Balance – September 30, 2023 (unaudited)   1,322,000   $132    10,000,000   $900   $
   $(18,987,646)  $(18,986,614)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

 

   Ordinary Shares   Additional       Total 
   Class A   Class B   Paid-in   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance - December 31, 2021   1,322,000   $132    10,000,000   $900   $
   $(21,859,293)  $(21,858,261)
Net income       
        
    
    4,313,808    4,313,808 
Balance - March 31, 2022 (Unaudited)   1,322,000    132    10,000,000    900    
    (17,545,485)   (17,544,453)
Net income       
        
    
    3,538,542    3,538,542 
Increase in redemption value of Class A ordinary shares subject to possible redemption       
        
    
    (47,289)   (47,289)
Balance - June 30, 2022 (Unaudited)   1,322,000    132    10,000,000    900    
    (14,054,232)   (14,053,200)
Net income       
        
    
    431,405    431,405 
Increase in redemption value of Class A ordinary shares subject to possible redemption       
        
    
    (1,533,315)   (1,533,315)
Balance - September 30, 2022 (Unaudited)   1,322,000   $132    10,000,000   $900   $
   $(15,156,142)  $(15,155,110)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the Nine months Ended
September 30,
 
   2023   2022 
Cash Flows from Operating Activities:        
Net income  $672,085   $8,283,755 
Adjustments to reconcile net income to net cash used in operating activities:          
Change in fair value of derivative warrant liabilities   (255,274)   (9,827,277)
Change in fair value of forward purchase agreement   (273,529)   
 
Income earned on investments held in Trust Account   (2,986,102)   (1,679,514)
Changes in operating assets and liabilities:          
Prepaid expenses   321,406    244,802 
Accounts payable   1,239,891    155,843 
Accrued expenses   7,778    2,387,500 
Net cash used in operating activities   (1,273,745)   (434,891)
           
Cash Flows from Investing Activities:          
Cash withdrawn from trust account for redemptions   274,207,726    
 
Net cash provided by investing activities   274,207,726    
 
           
Cash Flows from Financing Activities:          
Proceeds from note payable to related party   1,241,420    170,000 
Offering costs paid   
    (30,000)
Redemption of Class A Ordinary Shares   (274,207,726)   
 
Net cash (used in) provided by financing activities   (272,966,306)   140,000 
           
Net change in cash   (32,325)   (294,891)
Cash - beginning of the period   254,781    380,035 
Cash - end of the period  $222,456   $85,144 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Organization and Business Operations

 

Blockchain Coinvestors Acquisition Corp. I (the “Company”) was incorporated as a Cayman Islands exempted company on June 11, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activity for the period from June 11, 2021 (inception) through September 30, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

 

The Company’s sponsor is Blockchain Coinvestors Acquisition Sponsors I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 9, 2021 (the “Effective Date”). On November 15, 2021, the Company commenced the Initial Public Offering of 30,000,000 units (the “Units”) at $10.00 per unit, including the issuance of 3,900,000 Units as a result of the underwriters’ partial exercise of the over-allotment option, which is discussed in Note 4. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

 

Simultaneously with the consummation of the Initial Public Offering and partial exercise of the over-allotment option by the underwriters, the Company consummated the private placement of 1,322,000 units (the “Private Placement Units”) with the Sponsor, at a price of $10.00 per Private Placement Unit. Transaction costs amounted to $17,800,002, consisting of $5,220,000 of underwriting commissions, $11,280,000 of deferred underwriting commissions, and $1,300,002 of other offering costs.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding any deferred underwriters’ commission and taxes payable on the interest income earned on the Trust Account at the time of the Company’s signing of a definitive agreement in connection with the initial Business Combination) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

 

Following the closing of the Initial Public Offering and partial exercise of the over-allotment by the underwriters on November 15, 2021, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was deposited into a trust account (the “Trust Account”) and were subsequently invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company intends to maintain trust funds only in demand deposit accounts after November 15, 2023.

 

5

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The Company will provide holders of its Class A ordinary shares, par value $0.0001, originally sold in the Initial Public Offering (the “Public Shares” and such holders, the “Public Shareholders”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement. Asset acquisitions and share purchases would not typically require shareholder approval, while direct mergers with the Company where the Company does not survive and any transactions, where the Company issues more than 20% of the outstanding ordinary shares or seek to amend its memorandum and articles of association would typically require shareholder approval. The Company currently intends to conduct redemptions in connection with a shareholder vote unless shareholder approval is not required by applicable law or stock exchange listing requirements or the Company chooses to conduct redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) for business or other reasons. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).

 

Notwithstanding the foregoing, the Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares originally sold in the Initial Public Offering, without the prior consent of the Company.

 

The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the time period set forth in its Amended and Restated Memorandum and Articles of Association, as may be amended from time to time or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

 

The Company had 18 months from the closing of the Initial Public Offering to consummate the initial Business Combination, which has been subsequently extended to May 15, 2024 (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and the Combination Period is not further extended, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor and each member of the Company’s management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to the ordinary shares of the Company that they received in connection with the Company's initial public offering in connection with the completion of a Business Combination; (ii) waive their redemption rights with respect to the ordinary shares that they received in connection with the Company's initial public offering in connection with a shareholder vote to approve an amendment to the Company’s Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares; and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their ordinary shares of the Company that they received in connection with the Company's initial public offering if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

Business Combination

 

On November 10, 2022, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among the Company, BCSA Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Qenta Inc., a Delaware corporation (“Qenta”).

 

6

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Qenta. The Business Combination Agreement provides for, among other things, the following transactions: (i) the Company would become a Delaware corporation (the “Domestication”) and, in connection with the Domestication, (A) the Company’s name would be changed to “Qenta Inc.” (“New Qenta”) and (B) each outstanding ordinary share of the Company will become one share of common stock of New Qenta (the “New Qenta Common Stock”); and (ii) following the Domestication, Merger Sub would merge with and into Qenta, with Qenta as the surviving company in the merger and continuing as a wholly owned subsidiary of New Qenta (the “Merger”).

 

The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are referred to as the “Qenta Business Combination.

 

On August 24, 2023, the Company, Merger Sub, and Qenta entered into an amendment (the “First BCA Amendment”) to the Business Combination agreement, to, among other things, extend the Termination Date (as defined in the Business Combination Agreement) until May 15, 2024. In addition, under the terms of the First BCA Amendment, Qenta agreed to deliver to the Company specified financial statements and other financial information by specified deadlines (the “Financial Information Obligations”), and the Company agreed not to exercise, but did not waive, BCSA’s Financial Statement Termination Right (as defined in the Business Combination Agreement) unless Qenta failed to comply with the Financial Information Obligations.  Qenta failed to meet the first specified Financial Information Obligations deadline.

 

On August 29, 2023, the Company, Merger Sub, and Qenta entered into a second amendment (the “Second BCA Amendment”) to the Business Combination Agreement to eliminate the exclusive dealing provision applicable to the Company and to limit the exclusive dealing provision applicable to Qenta to transactions involving special purpose acquisition companies and similar “blank check” companies.

 

On August 24, 2023, the Company, Sponsor and Qenta entered into an amendment (the “Sponsor Letter Amendment”) to the Sponsor Letter Agreement, dated as of November 10, 2022, by and among the Company, the Sponsor and Qenta, pursuant to which the Sponsor agreed, in connection with the completion of a financing transaction between Qenta and financing parties, to transfer and assign, contingent and conditioned upon the closing of the transactions contemplated by the Business Combination Agreement, up to 3,178,000 of the Sponsor’s Class B ordinary shares of the Company (or, if converted, Class A ordinary shares) and 1,322,000 of the Sponsor’s private placement units of the Company to such financing parties or to Qenta in such amounts and proportions as designated by Qenta, provided that all transferees of such shares or units, as applicable, execute and deliver to the Company a lockup agreement in respect of such securities.

 

In connection with the execution of the Business Combination Agreement, the Company entered into a Confirmation (the “Forward Purchase Agreement”), with Vellar Opportunity Fund SPV LLC—Series 5 (the “FPA Seller”), a client of Cohen & Company Financial Management, LLC (“Cohen”). Entities and funds managed by Cohen own equity interests in the Sponsor. The primary purpose of entering into the Forward Purchase Agreement was to help ensure the aggregate cash proceeds condition in the Business Combination Agreement would be met, increasing the likelihood that the transaction would close. Pursuant to the Forward Purchase Agreement, (a) the FPA Seller could have, but was not obligated to, purchase after the date of the Company’s redemption deadline through a broker in the open market the Company’s Class A ordinary shares, including such shares that holders had elected to redeem pursuant to the Company’s organizational documents in connection with the Qenta Business Combination, other than from the Company or affiliates of the Company, and (b) the FPA Seller agreed to waive any redemption rights in connection with the Qenta Business Combination with respect to such Class A ordinary shares of the Company it purchased in accordance with the Forward Purchase Agreement (the “Subject Shares”). See Note 6 where the Forward Purchase Agreement is more fully described.

 

On November 8, 2023, the Company delivered to Qenta written notice of its election to terminate the Business Combination Agreement pursuant to Section 7.1(h) thereof, and abandoned the Qenta Business Combination.

 

In conjunction with the termination of the Business Combination Agreement, the Lock-up Agreements, Sponsor Letter Agreement, Transaction Support Agreements and Forward Purchase Agreement were also terminated in accordance with their respective terms.

 

7

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The full Business Combination Agreement, Forward Purchase Agreement, related amendments and other agreements entered into or contemplated to be executed prior to closing the Qenta Business Combination were included with the Company’s Current Reports on Form 8-K filed with the SEC on November 10, 2022 and August 30, 2023.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make the comparison of the Company’s condensed consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Going Concern, Liquidity and Capital Resources

 

As of September 30, 2023, the Company had approximately $222,000 in its operating bank account and working capital deficit of approximately $6.8 million, inclusive of convertible note payable – related party of approximately $1.8 million.

 

The Company’s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares (as defined in Note 5) to cover certain offering costs and through the loan under an unsecured promissory note from the Sponsor of $131,517 (see Note 5) and the proceeds from the consummation of the Private Placement not held in the Trust Account. The promissory note was paid in full on November 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, initial shareholders, officers, directors or their affiliates may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). On June 15, 2022, the Company issued a promissory note (the “Sponsor Note”) in the principal amount of up to $1,500,000 to the Sponsor, which was amended effective June 2023 to increase the maximum principal amount to $3,000,000 (see Note 5). As of September 30, 2023, the Company has drawn down a total of $1,767,244 and still can borrow up $1,232,756 on the Sponsor Note.

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until May 15, 2024 to consummate a Business Combination. The Company does not have adequate liquidity to sustain operations; however, the Company has access to a Working Capital Loan from the Sponsor that management believes will enable the Company to sustain operations until it completes its initial Business Combination. If a Business Combination is not consummated by May 15, 2024, and such deadline to consummate a Business Combination is not further extended, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the Company’s liquidity issue, mandatory liquidation should a Business Combination not occur by the applicable deadline, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 15, 2024. There can be no assurance that the Company will be able to consummate any Business Combination by May 15, 2024.

 

8

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Risks and Uncertainties

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed unaudited consolidated financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed consolidated financial statements.

 

On May 1, 2023, First Republic Bank became insolvent. Federal regulators seized the assets of the bank and negotiated a sale of its assets to JP Morgan Chase. The Company held deposits with this bank. As a result of the sale of the assets to JP Morgan Chase, the Company’s insured and uninsured deposits are held at JP Morgan Chase. The Company also moved the funds held in trust for the shareholders and invested in federal government securities through Morgan Stanley.

 

Note 2 — Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023, or any future period.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 17, 2023.

 

Principles of Consolidation

 

The unaudited condensed consolidated financial statements of the Company include its wholly owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in the accompanying unaudited condensed consolidated financial statements is the determination of the fair value of derivative warrant liabilities. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2023 and December 31, 2022.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income earned on investments held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

9

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Convertible Promissory Note —Related Party, Fair Value

 

The Company entered into a convertible promissory note with its Sponsor on June 15, 2022. The Company has elected the fair value option to account for proceeds received during 2022. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Fair Value.” The primary reason for electing the fair value option in the 2022 proceeds is to provide better information on the financial liability amount given current market and economic conditions of the Company. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value recorded as change in the fair value of convertible note—related party on the accompanying unaudited condensed consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.

 

Convertible Promissory Note —Related Party, Par Value

 

The Company has elected the bifurcated option to account for proceeds received during 2023 from the Convertible promissory notes with its Sponsor on June 2023. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Par Value.”

 

The Company analyzed the Convertible Promissory Note – Related Party to assess if the fair value option was appropriate in 2023, due to the substantial premium which results in an offsetting entry to additional paid in capital and under the related party guidance which precludes the fair value option it was determined the fair value option was not appropriate. As such, the Company accounted for the Convertible Promissory Note – Related Party, Par Value, analyzing the conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.

 

The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

 

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as nonoperating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.

 

It was determined that the previous conversion option was de minimis, as such the Company has recorded the Convertible Promissory Note – Related Party at par value through the rest of the note’s use.

 

10

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Derivative Liabilities

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants was estimated using a stochastic trinomial tree model. The determination of the fair value of the warrants may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

The Company determined the Forward Purchase Agreement (defined in Note 1) is a derivative instrument. Accordingly, the Company recognizes the instrument as an asset or liability at fair value and adjusts the instrument to fair value at each reporting period. Any changes in fair value are recognized on the Company’s unaudited condensed consolidated statements of operations. The estimated fair value of the Forward Purchase Agreement is measured at fair value utilizing a Monte Carlo simulation model.

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. As part of the Private Placement, the Company issued 1,322,000 Class A ordinary shares to the Sponsor (“Private Placement Shares”). These Private Placement Shares will not be transferable, assignable or saleable until 30 days after the completion of the initial Business Combination, as such they are considered non-redeemable and presented as permanent equity in the Company’s condensed consolidated balance sheets. Excluding the Private Placement Shares, the Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 3,593,271 and 30,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed consolidated balance sheets, respectively.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in redemption value of Class A ordinary shares subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.

 

Income Taxes

 

The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

11

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

 

Net Income per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.

 

The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 15,661,000 Class A ordinary shares because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

 

The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each period presented:

 

   For the Three Months Ended September 30,   For the Nine months Ended September 30, 
   2023   2022   2023   2022 
   Class A   Class B   Class A   Class B   Class A   Class B   Class A   Class B 
Basic and diluted net income per ordinary share:                                
Numerator:                                
Allocation of net income  $143,528   $292,005   $327,004   $104,401   $314,296   $357,789   $6,279,071   $2,004,684 
Denominator:                                        
Basic and diluted weighted average ordinary shares outstanding
   4,915,271    10,000,000    31,322,000    10,000,000    8,784,389    10,000,000    31,322,000    10,000,000 
Basic and diluted net income per ordinary share
  $0.03   $0.03   $0.01   $0.01   $0.04   $0.04   $0.20   $0.20 

 

Recent Accounting Standards

 

In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its condensed consolidated financial statements.

 

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

 

12

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 3 — Initial Public Offering

 

On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 Units from the partial exercise of over-allotment option at a purchase price of $10.00 per Unit. Each Unit that the Company offered had a price of $10.00 and consisted of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9).

 

Following the closing of the Initial Public Offering and the partial exercise of the over-allotment by the underwriters on November 15, 2021, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units, was placed in a Trust Account.

 

Note 4 — Private Placement

 

Simultaneously with the closing of the Initial Public Offering and partial exercise of the over-allotment option by the underwriters, the Company’s Sponsor purchased an aggregate of 1,322,000 Private Placement Units, at a price of $10.00 per Unit, or $13,220,000 in the aggregate, in a private placement.

 

Each Private Placement Unit consists of one share of Class A ordinary share and one-half of one warrant (the “Private Placement Warrant”). Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable except as described below in Note 9 and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

 

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination or 12 months from the closing of the Initial Public Offering.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On July 2, 2021, the Sponsor paid $25,000, or approximately $0.003 per share, in consideration for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). Effective November 9, 2021, the Company effected a stock split and a stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which were subject to forfeiture if the over-allotment option were not exercised in full or in part by the underwriters. At the Initial Public Offering, the underwriters partially exercised their over-allotment option resulting in 5,000 Founder Shares being forfeited, such that the Founder Shares represented approximately 25% of the Company’s issued and outstanding shares after the Initial Public Offering (excluding Private Placement Shares), and 1,300,000 shares no longer being subject to forfeiture.

 

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.

 

Promissory Note—Related Party

 

On July 2, 2021, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of September 30, 2022 or the completion of the Initial Public Offering. The aggregate amount of $131,517 was paid in full on November 15, 2021 upon closing of the Initial Public Offering. Subsequent to the repayment, the facility was no longer available to the Company.

 

13

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement units at a price of $10.00 per unit.

 

Convertible Promissory Notes – Related Party, Fair Value and Par Value

 

On June 15, 2022, the Company issued a promissory note for a Working Capital Loan, as described above, of $1,500,000 to the Sponsor for the Sponsor to provide additional working capital to the Company on an as-needed basis toward the consummation of a Business Combination. The Sponsor Note was amended effective June 29, 2023 to increase the maximum principal amount to $3,000,000. Proceeds from the Trust Account may only be used to pay off outstanding working capital loans under this promissory note upon the closing of the Business Combination. The Sponsor Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor, all or any portion of the Sponsor Note may be converted into units of the Company upon the consummation of an initial Business Combination (the “Conversion Units”), equal to (x) the portion of the principal amount of the Sponsor Note being converted, divided by (y) $10.00. The Conversion Units are identical to the Private Placement Units issued by the Company to the Sponsor in connection with the Company’s Initial Public Offering. As of September 30, 2023, principal in the amount of $1,767,244 was outstanding, leaving $1,232,756 of borrowing capacity under the Sponsor Note.

 

As of September 30, 2023 and December 31, 2022, the portion of the Sponsor Note carried under the fair value method is described as “Convertible Promissory Note – Related Party, Fair Value” on the accompanying condensed consolidated balance sheets with a balance of $525,824, respectively. The 2022 proceeds from principal on the Convertible Promissory Note – Related Party, Fair Value totaled $512,000, and were historically fair valued to the amount of $525,824, containing a $13,824 change in value recorded on the statement of operations for the year ended December 31, 2022. There were no changes in fair value or principal recorded during the period ended September 30, 2023.

 

During the period ended September 30, 2023, the Company has concluded that the fair value of the conversion feature on 2023 proceeds from principal, require bifurcation under ASC 815 and is considered de minimis. The underlying economics of the transaction are more accurately represented by recording this portion of the convertible debt agreement as a liability at par value given the de minimis value of the embedded conversion feature in this case.

 

As of September 30, 2023, a portion of the Sponsor Note carried under the bifurcation method is described as “Convertible Promissory Note – Related Party, Par Value” on the accompanying condensed consolidated balance sheets with a balance of $1,241,420, as of December 31, 2022, the balance was zero. 2023 proceeds from principal on the Convertible Promissory Note – Related Party, Par Value totaled $1,241,420.

 

Administrative Services Agreement

 

Commencing on the date the securities are first listed on Nasdaq, the Company has agreed to pay the Sponsor a total of $15,000 per month for secretarial and administrative support services provided to the Company. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2022, the Company incurred expenses of approximately $45,000 and $135,000, respectively, under this agreement. For the three and nine months ended September 30, 2023, the Company incurred expenses of approximately $28,671 and $107,490 under this agreement, respectively. As of September 30, 2023, and December 31, 2022, approximately $14,900 and approximately $106,000, respectively, were due for administrative services in connection with such agreement and have been included in the accrued expenses of the accompanying unaudited condensed consolidated balance sheets.

 

In addition, the Sponsor, executive officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

 

14

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 6 — Commitments and Contingencies

 

Registration and Shareholder Rights

 

The holders of Founder Shares, Private Placement Warrants and securities included in private placement units that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement entered into in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggyback” registration rights with respect to registration statements filed after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreements and Amendments

 

The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,915,000 Units to cover over-allotments, if any. On November 15, 2021, the underwriters partially exercised the over-allotment and the unexercised portion of the over-allotment of 15,000 units was forfeited. The underwriters were paid underwriting commission of $0.20 per unit, or $5,220,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, $11,280,000 in the aggregate, is payable to the underwriters for deferred underwriting commissions. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

 

The Company entered into an amended agreement with one of its underwriters (Cantor Fitzgerald) to reduce the amount of deferred underwriting fees associated with the Qenta Business Combination. Upon the successful completion of the Qenta Business Combination, the $7,896,000 deferred underwriting fee owed to Cantor Fitzgerald would have been reduced to $3,948,000.

 

Forward Share Purchase Agreement

 

In connection with the execution of the Business Combination Agreement, the Company entered into the Forward Purchase Agreement. Pursuant to the Forward Purchase Agreement, (a) the FPA Seller could have, but was not obligated to, purchase after the date of the Company’s redemption deadline through a broker in the open market the Company’s Class A ordinary shares, including such shares that holders had elected to redeem pursuant to the Company’s organizational documents in connection with the Qenta Business Combination, other than from the Company or affiliates of the Company, and (b) the FPA Seller agreed to waive any redemption rights in connection with the Qenta Business Combination with respect to such Class A ordinary shares of the Company it purchased in accordance with the Forward Purchase Agreement (the “Subject Shares”). The Number of Shares were to equal the Subject Shares but be no more than 12,000,000 Shares. The FPA Seller agreed to not beneficially own more than 9.9% of the New Qenta Common Stock on a post-combination pro forma basis.

 

The Forward Purchase Agreement provided that (a) one business day following the closing of the Qenta Business Combination, New Qenta would pay to the FPA Seller, out of the Trust Account, an amount (the “Prepayment Amount”) equal to the Redemption Price per share (the “Initial Price”) multiplied by the aggregate number of Subject Shares, if any (together, the “Number of Shares”), less 10% (the “Shortfall Amount”) on the date of such prepayment. New Qenta would also deliver the FPA Seller an amount equal to the product of 500,000 multiplied by the Redemption Price to repay the FPA Seller for having purchased up to an additional 500,000 Class A ordinary shares of the Company, which would not be included in the Number of Shares or the Terminated Shares (as defined in the Forward Purchase Agreement).

 

From time to time and on any scheduled trading day after the closing of the Qenta Business Combination, the FPA Seller could have sold Subject Shares or Additional Shares (as defined in the Forward Purchase Agreement) at its absolute discretion in one or more transactions, publicly or privately, and, in connection with such sales, terminate the Forward Purchase Transaction in whole or in part in an amount corresponding to the number of Subject Shares and Additional Shares.

 

15

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The Forward Purchase Agreement had a tenure of 36 months (“Maturity Date”), after which time New Qenta would be required to purchase from the FPA Seller such number of shares equal to the Maximum Number of Shares (as defined in the Forward Purchase Agreement) less the Terminated Shares (as defined in the Forward Purchase Agreement) for consideration, settled in cash or New Qenta Common Stock, equal to the Maturity Consideration, which is the amount of (a) in the case of cash, the product of the Maximum Number of Shares less the Terminated Shares and $1.75 and (b) in the case of New Qenta Common Stock, such number of New Qenta Common Stock with a value equal to the product of the Maximum Number of Shares less the Terminated Shares and $1.75 divided by the VWAP Price of the Shares for the 30 trading days prior to the Maturity Date. In certain circumstances, the Maturity Date could have been accelerated, as described in the Forward Purchase Agreement.

 

The Company and Qenta agreed to pay to the FPA Seller a break-up fee equal to the sum of (i) all fees (in an amount not to exceed $75,000), plus (ii) $350,000, if the Company or Qenta were to terminate the Forward Purchase Agreement prior to the FPA Sellers purchasing shares under the agreement, other than because the Qenta Business Combination did not close, or Class A Ordinary Share redemptions were less than 80%.

 

The primary purpose of entering into the Forward Purchase Agreement was to help ensure the aggregate cash proceeds condition in the Business Combination Agreement would be met, increasing the likelihood that the transaction would close.

 

In conjunction with the termination of the Business Combination Agreement, the Forward Purchase Agreement was terminated in accordance with its terms on November 8, 2023.

 

Shareholder Meetings, Extensions, and Redemptions

 

On February 3, 2023, the Company held an extraordinary general meeting (the “Shareholder Meeting”) at which the Company’s shareholders approved a proposal to amend the Company’s amended and restated memorandum and articles of association (the “Memorandum and Articles of Association”) to extend the date by which it has to consummate a business combination from May 15, 2023 to November 15, 2023 (the “Extension Amendment Proposal”). The Extension Amendment Proposal is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on December 29, 2022.

 

In connection with the vote to approve the Extension Amendment Proposal, holders of 26,406,729 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.38 per share, for an aggregate redemption amount of approximately $274.2 million. As a result, approximately $274.2 million has been removed from the Trust Account to redeem such shares and 4,915,271 Class A ordinary shares remain outstanding after the redemption, including 1,322,000 shares underlying the Private Placement Units. Upon payment of the redemption, approximately $37.3 million remained in the Trust Account.

 

On October 27, 2023, the Company held an extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders (the “Second Shareholder Meeting”) at which the Company shareholders approved proposals to amend the Company’s amended and restated memorandum and articles of association to (i) extend the date by which BCSA must consummate a business combination from November 15, 2023 to May 15, 2024 or such earlier date as may be determined by the Company’s board of directors in its sole discretion (the “Second Extension Amendment Proposal”), (ii) eliminate the limitation that the Company may not redeem its Class A ordinary shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of a business combination (the “Redemption Limitation Amendment Proposal”), and (iii) permit for the issuance of Class A Shares to holders of the Company’s Class B ordinary shares (“Founder Shares”) upon the exercise of the right of a holder of BCSA’s Founder Shares to convert such holder’s Founder Shares into Class A Shares on a one-for-one basis at any time and from time to time prior to the closing of an initial business combination at the election of the holder (the “Founder Share Amendment Proposal,” and together with the Second Extension Amendment Proposal and the Redemption Limitation Amendment Proposal, the “Articles Amendment Proposals”). The Articles Amendment Proposals are described in more detail in BCSA’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 5, 2023.

 

In connection with the approval of the Founder Share Amendment Proposal, the Sponsor voluntarily elected to convert all 9,850,000 of its Founder Shares to Class A Shares, and the independent directors of BCSA voluntarily elected to convert all 150,000 of their Founder Shares to Class A Shares, in each case, on a one-for-one basis in accordance with the Memorandum and Articles of Association (such conversions collectively, the “Founder Share Conversion”). The Sponsor and the independent directors waived any right to receive funds from the trust account established by the Company in connection with its initial public offering with respect to the Class A Shares received upon such conversion and no additional amounts were deposited into the Trust Account in respect of any of those Class A Shares.

 

In connection with the vote to approve the Articles Amendment Proposals, holders of 1,481,477 Class A Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $16.2 million (approximately $10.91 per share) was removed from the Trust Account to redeem such shares. Upon payment of the redemption, and after giving effect to the Founder Share Conversion, BCSA has approximately 13,433,794 Class A Shares outstanding, including 2,111,794 Class A Shares having a right to request redemptions for a pro rata portion of the funds remaining in the Trust Account.

 

16

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Vendor Agreements Contingent on the Business Combination

 

The Company entered into an agreement with a vendor for merger advisory services and the total fee will be $6,200,000, contingent upon completion of the Qenta Business Combination.

 

In January 2023, the Company entered into an agreement with a vendor for investment banking services. The agreement specifies that upon a successful Business Combination, the Company will owe a fee of $1,250,000 which is payable in cash or equity at the Company’s option.

 

Non-redemption Agreements

 

The Sponsor entered into Non-Redemption Agreements with various shareholders of the Company (the “Non-Redeeming Shareholders”), pursuant to which these shareholders agreed not to redeem a portion of their shares of Company common stock (the “Non-Redeemed Shares”) in connection with the Special Meeting held on February 3, 2023, but such shareholders retained their right to require the Company to redeem such Non-Redeemed Shares in connection with the closing of the Business Combination. The Sponsor has agreed to transfer to such Non-Redeeming shareholders an aggregate of 739,286 the Founder Shares held by the Sponsor immediately following the consummation of an initial Business Combination. The Company estimated the aggregate fair value of such 739,286 Founder Shares transferrable to the Non-Redeeming shareholders pursuant to the Non-Redemption Agreement to be $155,250 or $0.21 per share. The fair value was determined using the probability of a successful Business Combination of 2.25%, a volatility of 60.0%, a discount for lack or marketability of $1.04 and the value per shares as of the valuation date of $9.32 derived from an option pricing model for publicly traded warrants. Each Non-Redeeming Shareholder acquired from the Sponsor an indirect economic interest in such Founder Shares. The excess of the fair value of such Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, it was recognized by the Company as a capital contribution by the Sponsor to induce these Non-Redeeming Shareholders not to redeem the Non-Redeemed Shares, with a corresponding charge to additional paid-in capital to recognize the fair value of the Founder Shares subject to transfer as an offering cost.

 

Note 7 — Class A Ordinary Shares Subject to Possible Redemption

 

The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 3,593,271 and 30,000,000 Class A ordinary shares subject to possible redemption, respectively.

 

The Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:

 

Gross proceeds from Initial Public Offering  $300,000,000 
Less:     
Fair value of Public Warrants at issuance   (11,113,500)
Offering Costs allocated to Class A ordinary shares subject to possible redemption   (17,088,566)
Plus:     
Increase in redemption value of Class A ordinary shares subject to possible redemption   38,365,280 
Class A ordinary shares subject to possible redemption as of December 31, 2022   310,163,214 
Less:     
Redemption   (274,207,726)
Increase in redemption value of Class A ordinary shares subject to possible redemption   2,986,102 
Class A ordinary shares subject to possible redemption as of September 30, 2023  $38,941,590 

 

Note 8 — Shareholders’ Deficit

 

Preference shares—The Company is authorized to issue 5,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023, and December 31, 2022, there were no preference shares issued or outstanding.

 

17

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Class A ordinary shares—The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023, and December 31, 2022, there were 4,915,271 and 31,322,000 Class A ordinary shares issued and outstanding, of which 3,593,271 and 30,000,000 shares were subject to possible redemption and have been classified as temporary equity, respectively (see Note 7).

 

Class B ordinary shares—The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.00009 per share. At July 2, 2021, there were 8,625,000 Class B ordinary shares issued and outstanding. Class B ordinary shares are subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that initial shareholders will collectively own approximately 25% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding the Private Placement Shares). On November 9, 2021, the Company effected a 1.1111111-for-1 stock split and a 379,500 Class B ordinary share stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which were subject to forfeiture if the over-allotment option were not exercised in full or in part by the underwriters. As a result of the stock split, the par value of Class B ordinary shares was lowered to $0.00009. On November 15, 2021, the underwriters partially exercised their over-allotment option resulting in 5,000 shares being forfeited and 10,000,000 Class B ordinary shares issued and outstanding. As of September 30, 2023, and December 31, 2022, there were 10,000,000 shares issued and outstanding.

 

Prior to the initial Business Combination, only holders of Class B ordinary shares will have the right to vote on the appointment of directors. In addition, in a vote to continue the company in a jurisdiction outside the Cayman Islands (which requires the approval of at least two thirds of the votes of all ordinary shares voted at a general meeting), holders of the Class B ordinary shares will have ten votes for every Class B ordinary share and holders of Class A ordinary shares will have one vote for every Class A ordinary share. Holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of Class B ordinary shares may remove a member of the board of directors for any reason. With respect to any other matter submitted to a vote of the shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of Class B and Class A ordinary shares will vote together as a single class, with each share entitling the holder to one vote.

 

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, approximately 25% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Units (and securities included in the units) issued to the Sponsor, its affiliates or any member of the management team in the Private Placement or upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

 

Note 9 — Warrants

 

As of September 30, 2023, and December 31, 2022, the Company had 15,000,000 Public Warrants and 661,000 Private Placement Warrants outstanding.

 

The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

18

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market value and the Newly Issued Price.

 

The warrants underlying the Private Placement Units (the “Private Placement Warrants”) are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

  in whole and not in part;

 

  at a price of $0.01 per warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption; and

 

  if, and only if, the Redemption Reference Price equals or exceeds $18.00 per share (as adjusted).

 

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

19

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 10 — Fair Value Measurements

 

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

 

September 30, 2023

 

Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $39,041,590   $
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $   $655,500   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $28,886 
Forward Purchase Agreement  $
   $
   $368,038 
Convertible note – related party  $
   $
   $525,824 

 

December 31, 2022

 

Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $310,263,214   $
      —
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $
   $900,000   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $39,660 
Forward Purchase Agreement  $
   $
   $641,567 
Convertible note – related party  $
   $
   $525,824 

 

Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period.

 

The Company values its investments held in money market accounts as Level 1 instruments, since they include investments in money market funds invested in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

 

The estimated fair value of Public Warrants for $10,500,000 was transferred from a Level 3 fair value measurement to Level 1 and Level 2 measurements when the Public Warrants were separately listed and traded in January 2022. The initial fair value of the Public Warrants and Private Placement Warrants was measured at fair value using a stochastic trinomial tree model, a Level 3 Measurement. On December 31, 2022 the Public Warrants were transferred to a Level 2 Measurement, due to limited traded volume. During January 2023, the Public warrants traded at a higher volume and were measured as a Level 1 Measurement on March 31, 2023. During September 2023, on or around period end, the Public Warrants were transferred to a Level 2 measurement, due to a limited trading volume.

 

The estimated fair value of the Private Placement Warrants is determined using Level 3 input during the IPO of the Company in November 2021. The Company used a stochastic trinomial tree model to value the Private Placement warrants, wherein input assumptions are related to expected flat volatility, expected life, risk-free rate and dividend yield. There have been no transfers to/from levels 1, 2 or 3 for Private Placement Warrants during the reporting period ending September 30, 2023 and year ended December 31, 2022.

 

The Company used an intrinsic value model to determine the fair value of the Convertible note at December 31, 2022. As of September 30, 2023 and December 31, 2022, the portion of the Sponsor Note carried under the fair value method is described as “Convertible Promissory Note – Related Party, Fair Value” on the accompanying condensed consolidated balance sheets with a balance of $525,824, respectively. The 2022 proceeds from principal on the Convertible Promissory Note – Related Party, Fair Value totaled $512,000, and were historically fair valued to the amount of $525,824, containing a $13,824 change in value recorded on the statement of operations for the year ended December 31, 2022. There were no changes in fair value or principle recorded during the period ended September 30, 2023.

 

20

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

During the period ended June 30, 2023, the Company has concluded that the fair value of the conversion feature on 2023 proceeds from principal, require bifurcation under ASC 815 and is considered de minimis. The underlying economics of the transaction are more accurately represented by recording this portion of the convertible debt agreement as a liability at par value given the de minimis value of the embedded conversion feature in this case.

 

The estimated fair value of the Forward Purchase Agreement was measured at fair value using a Monte Carlo simulation model, which was determined using Level 3 inputs. Inherent in the Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, expected Business Combination close date and probability of a successful transaction. The Company estimates the volatility based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. Any changes in these assumptions can change the valuation significantly.

 

For the three and nine months ended September 30, 2023, the Company recognized a gain of approximately $189,000 and $255,000, respectively, resulting from a change in the fair value of derivative liabilities, which represent changes in fair value of the Private Placement Warrants and the FPA, presented as change in fair value of derivative liabilities on the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2022, the Company recognized a gain of approximately $117,000 and $9.8 million, respectively.

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the derivative Private Placement warrant liabilities:

 

   September 30,
2023
   December 31,
2022
 
Exercise price  $11.50   $11.50 
Stock price  $10.80   $10.24 
Volatility   3.5%   1.5%
Term (years)   5    5 
Risk-free rate   2.00%   2.00%
Dividend yield   0.0%   0.0%

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the Forward Purchase Agreement derivative liabilities:

 

   September 30,
2023
   December 31,
2022
 
Probability of a Business Combination Close   1.00%   1.5%
Stock price as of Valuation Date  $10.80   $10.24 
Expected Stock price as of Business Combination Date  $11.45   $10.51 
Risk-Free Rate   4.74%   4.18%

 

The change in the fair value of derivative liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2023 and 2022 is summarized as follows:

 

Derivative warrant liabilities at December 31, 2022  $681,227 
Change in fair value of derivative liabilities   525,603 
Derivative warrant liabilities at March 31, 2023   1,206,830 
Change in fair value of derivative liabilities   (674,951)
Derivative warrant liabilities at June 30, 2023   531,879 
Change in fair value of derivative liabilities   (135,955)
Derivative warrant liabilities at September 30, 2023  $396,924 

 

Derivative warrant liabilities at December 31, 2021  $10,962,700 
Transfer of Public Warrants to Level 1   (10,500,000)
Change in fair value of derivative warrant liabilities   (198,300)
Derivative warrant liabilities at March 31, 2022   264,400 
Change in fair value of derivative warrant liabilities   (211,520)
Derivative warrant liabilities at June 30, 2022   52,880 
Change in fair value of derivative warrant liabilities   (4,957)
Derivative warrant liabilities at September 30, 2022  $47,923 

 

21

 

 

BLOCKCHAIN COINVESTORS ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The change in the fair value of the convertible note—related party, measured utilizing Level 3 measurements for the three and nine months ended September 30, 2023, is summarized as follows:

 

Working capital loan – related party at December 31, 2022—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at March 31, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at June 30, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at September 30, 2023—Level 3 measurement  $525,824 

 

Note 11 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed consolidated financial statements were issued. Based on this review, the Company did not identify any subsequent events, other than below, that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

 

On October 27, 2023, the Company held the Second Shareholder Meeting at which the Company shareholders approved (i) the Second Extension Amendment Proposal, (ii) (the Redemption Limitation Amendment Proposal), and (iii) (the Founder Share Amendment Proposal. The Articles Amendment Proposals are described in more detail in BCSA’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 5, 2023. In connection with the Second Shareholder Meeting, the Sponsor entered into Non-Redemption Agreements with several unaffiliated third parties and agreed to transfer an aggregate of 304,712 ordinary shares of the Company to such parties in exchange for them agreeing not to redeem an aggregate of 2,031,411 public shares at the Second Shareholder Meeting.

 

In connection with the approval of the Founder Share Amendment Proposal, the sponsor of the Company, voluntarily elected to convert all 9,850,000 of its Founder Shares to Class A Shares, and the independent directors of BCSA voluntarily elected to convert all 150,000 of their Founder Shares to Class A Shares, in each case, on a one-for-one basis in accordance with the Memorandum and Articles of Association (such conversions collectively, the “Founder Share Conversion”). The Sponsor and the independent directors waived any right to receive funds from the trust account established by the Company in connection with its initial public offering with respect to the Class A Shares received upon such conversion and no additional amounts were deposited into the Trust Account in respect of any of those Class A Shares.

 

In connection with the vote to approve the Articles Amendment Proposals, holders of 1,481,477 Class A Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $16.2 million (approximately $10.91 per share) was removed from the Trust Account to redeem such shares. Upon payment of the redemption, and after giving effect to the Founder Share Conversion, BCSA has approximately 13,433,794 Class A Shares outstanding, including 2,111,794 Class A Shares having a right to request redemptions for a pro rata portion of the funds remaining in the Trust Account. 

 

On November 8, 2023, the Company delivered to Qenta written notice of its election to terminate the Business Combination Agreement pursuant to Section 7.1(h) thereof, and abandoned the Qenta Business Combination, primarily based on Qenta’s failure to (i) deliver the Closing Company Financial Statements (as defined in the Business Combination Agreement) by the applicable deadline and (ii) comply with the Financial Information Obligations specified in the First BCA Amendment. In connection with the Sponsor’s obligations in support of the Qenta Business Combination and Qenta’s failure to meet the Financial Information Obligations, Qenta delivered to the Sponsor 50 shares of Qenta common stock to reimburse the Sponsor and the Company for costs, expenses and other liabilities incurred in connection with the Business Combination Agreement.

 

22

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “our,” “us” or “we” refer to Blockchain Coinvestors Acquisition Corp. I. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company on June 11, 2021. We were formed for the purpose of effectuating a Business Combination. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

 

Our Sponsor is Blockchain Coinvestors Acquisition Sponsors I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for our Initial Public Offering was declared effective on November 9, 2021. On November 15, 2021, we consummated our Initial Public Offering of 30,000,000 Units, including 3,900,000 additional Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $300,000,000, and incurring offering costs and expenses of approximately $17.8 million of which approximately $11.3 million was for deferred underwriting commissions.

 

Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share, and one-half of one redeemable warrant (each whole warrant, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share for $11.50 per whole share.

 

Simultaneously with the consummation of the closing of the Initial Public Offering, we consummated the Private Placement of an aggregate of 1,322,000 Private Placement Units at a price of $10.00 per Private Placement Unit with the Sponsor, generating total gross proceeds of $13,220,000.

 

Following the closing of the Initial Public Offering and partial exercise of the over-allotment by the underwriters on November 15, 2021, an amount of $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in the Trust Account in the United States maintained by Continental Stock Transfer & Trust Company, as trustee, and was invested, in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company. After November 15, 2023, the Company intends to maintain funds in the Trust Account in demand deposits.

 

Although we are not limited to a particular industry or sector for purposes of consummating a Business Combination, we have concentrated on sourcing business combination opportunities in the financial services, technology and other sectors of the economy that are being enabled by emerging applications of blockchain.

 

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that we will be able to complete a Business Combination successfully. The Nasdaq rules provide that the initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the Trust Account (excluding deferred underwriting costs and taxes payable on the income earned on the Trust Account) at the time of the Company’s signing a definitive agreement to enter a Business Combination. We will only complete a Business Combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

 

23

 

 

We had until 18 months from the closing of the Initial Public Offering to complete a Business Combination, which has been extended to May 15, 2024 as described below. If we are unable to complete a Business Combination within this Combination Period and the Combination Period is not further extended, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete a Business Combination within the Combination Period.

 

Shareholder Meeting, Extension, and Redemptions

 

On February 3, 2023, we held an extraordinary general meeting at which our shareholders approved a proposal to amend our Company’s amended and restated memorandum and articles of association to extend the date by which we have to consummate a business combination from May 15, 2023 to November 15, 2023 (the “Extension Amendment Proposal”). The Extension Amendment Proposal is described in more detail in our definitive proxy statement filed with the U.S. Securities and Exchange Commission on December 29, 2022.

 

In connection with the vote to approve the Extension Amendment Proposal, holders of 26,406,729 Class A ordinary shares of our Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.38 per share, for an aggregate redemption amount of approximately $274.2 million. As a result, approximately $274.2 million has been removed from the Trust Account to redeem such shares and 4,915,271 Class A ordinary shares remain outstanding after the redemption, including 1,322,000 shares underlying the Private Placement Units. Upon payment of the redemption, approximately $37.3 million remained in the Trust Account.

 

On October 27, 2023, the Company held an extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders (the “Second Shareholder Meeting”) at which the Company shareholders approved proposals to amend the Company’s amended and restated memorandum and articles of association to (i) extend the date by which BCSA must consummate a business combination from November 15, 2023 to May 15, 2024 or such earlier date as may be determined by the Company’s board of directors in its sole discretion (the “Second Extension Amendment Proposal”), (ii) eliminate the limitation that the Company may not redeem its Class A ordinary shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of a business combination (the “Redemption Limitation Amendment Proposal”), and (iii) permit for the issuance of Class A Shares to holders of the Company’s Class B ordinary shares (“Founder Shares”) upon the exercise of the right of a holder of BCSA’s Founder Shares to convert such holder’s Founder Shares into Class A Shares on a one-for-one basis at any time and from time to time prior to the closing of an initial business combination at the election of the holder (the “Founder Share Amendment Proposal,” and together with the Extension Amendment Proposal and the Redemption Limitation Amendment Proposal, the “Articles Amendment Proposals”). The Articles Amendment Proposals are described in more detail in BCSA’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 5, 2023.

 

In connection with the approval of the Founder Share Amendment Proposal, the sponsor of the Company, voluntarily elected to convert all 9,850,000 of its Founder Shares to Class A Shares, and the independent directors of BCSA voluntarily elected to convert all 150,000 of their Founder Shares to Class A Shares, in each case, on a one-for-one basis in accordance with the Memorandum and Articles of Association (such conversions collectively, the “Founder Share Conversion”). The Sponsor and the independent directors waived any right to receive funds from the trust account established by the Company in connection with its initial public offering with respect to the Class A Shares received upon such conversion and no additional amounts were deposited into the Trust Account in respect of any of those Class A Shares.

 

In connection with the vote to approve the Articles Amendment Proposals, holders of 1,481,477 Class A Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $16.2 million (approximately $10.91 per share) was removed from the Trust Account to redeem such shares. Upon payment of the redemption, and after giving effect to the Founder Share Conversion, BCSA has approximately 13,433,794 Class A Shares outstanding, including 2,111,794 Class A Shares having a right to request redemptions for a pro rata portion of the funds remaining in the Trust Account.

 

Business Combination

 

As more fully described in Note 1 to the condensed consolidated financial statements in Part I of this Quarterly Report on Form 10-10, on November 10, 2022, we entered into a Business Combination Agreement, with Merger Sub and Qenta Inc. The Business Combination Agreement provides for, among other things, the following transactions: (i) we will become a Delaware corporation and, in connection with the Domestication, (A) our name will be changed to “Qenta Inc.” and (B) each of our outstanding ordinary shares will become one share of common stock of New Qenta; and (ii) following the Domestication, Merger Sub will merge with and into Qenta, with Qenta as the surviving company in the merger and continuing as a wholly owned subsidiary of New Qenta.

 

24

 

 

On August 24, 2023, the Company, Merger Sub, and Qenta entered into an amendment (the “First BCA Amendment”) to the Business Combination agreement, to, among other things, extend the Termination Date (as defined in the Business Combination Agreement) until November 15, 2024. In addition, under the terms of the First BCA Amendment, Qenta agreed to deliver to the Company specified financial statements and other financial information by specified deadlines (the “Financial Information Obligations”), and the Company agreed not to exercise, but did not waive, BCSA’s Financial Statement Termination Right (as defined in the Business Combination Agreement) unless Qenta failed to comply with the Financial Information Obligations. As of November 1, 2023, Qenta failed to meet the first specified Financial Information Obligations deadline.

 

On August 29, 2023, the Company, Merger Sub, and Qenta entered into a second amendment (the “Second BCA Amendment”) to the Business Combination Agreement to eliminate the exclusive dealing provision applicable to the Company and to limit the exclusive dealing provision applicable to Qenta to transactions involving special purpose acquisition companies and similar “blank check” companies.

 

On August 24, 2023, the Company, Sponsor and Qenta entered into an amendment (the “Sponsor Letter Amendment”) to the Sponsor Letter Agreement, dated as of November 10, 2022, by and among the Company, the Sponsor and Qenta, pursuant to which the Sponsor agreed, in connection with the completion of a financing transaction between Qenta and financing parties, to transfer and assign, contingent and conditioned upon the closing of the transactions contemplated by the Business Combination Agreement, up to 3,178,000 of the Sponsor’s Class B ordinary shares of the Company (or, if converted, Class A ordinary shares) and 1,322,000 of the Sponsor’s private placement units of the Company to such financing parties or to Qenta in such amounts and proportions as designated by Qenta, provided that all transferees of such shares or units, as applicable, execute and deliver to the Company a lockup agreement in respect of such securities.

 

On November 8, 2023, the Company delivered to Qenta written notice of its election to terminate the Business Combination Agreement pursuant to Section 7.1(h) thereof, and abandoned the Qenta Business Combination, primarily based on Qenta’s failure to (i) deliver the Closing Company Financial Statements (as defined in the Business Combination Agreement) by the applicable deadline and (ii) comply with the Financial Information Obligations required by the First BCA Amendment. In connection with the Sponsor’s obligations in support of the Qenta Business Combination and Qenta’s failure to meet the Financial Information Obligations, Qenta delivered to the Sponsor 50 shares of Qenta common stock to reimburse the Sponsor and the Company for costs, expenses and other liabilities incurred in connection with the Business Combination Agreement.

 

In conjunction with the termination of the Business Combination Agreement, the Lock-up Agreements, Sponsor Letter Agreement, Transaction Support Agreements and Forward Purchase Agreement were also terminated in accordance with their respective terms.

 

Results of Operations

 

Our entire activity since June 11, 2021 (inception) up to September 30, 2023 was in preparation for our formation and the Initial Public Offering and since the Initial Public Offering, our search for prospective Business Combination. We will not generate any operating revenues until the closing and completion of our initial Business Combination. We generate non-operating income in the form of investment income from our investments held in the Trust Account.

 

For the three months ended September 30, 2023 we had net income of approximately $436,000 which consisted of a non-operating loss of approximately $189,000 from change in fair value of derivative liabilities, approximately $128,000 from change in fair value of forward purchase agreement and approximately $502,000 of income from investments held in the Trust Account, offset by approximately $0.3 million of general and administrative expenses and approximately $29,000 of general and administrative expenses to related party.

 

For the nine months ended September 30, 2023 we had net income of approximately $672,000 which consisted of approximately $255,000 in a non-operating loss from change in fair value of derivative liabilities, approximately $274,000 from change in fair value of forward purchase agreement and approximately $3 million of income from investments held in the Trust Account, offset by approximately $2.7 million of general and administrative expenses and approximately $107,000 of general and administrative expenses to related party.

 

25

 

 

For the three months ended September 30, 2022 we had net income of approximately $431,000 which consisted of approximately $117,000 in a non-operating gain from change in fair value of derivative liabilities, and approximately $1.5 million of income from investments held in the Trust Account, offset by approximately $1,174,000 of general and administrative expenses, and $45,000 of general and administrative expenses to related party.

 

For the nine months ended September 30, 2022 we had a net income of approximately $8.3 million, which consisted of approximately $9.8 million in non-operating gain from change in fair value of derivative liabilities, and approximately $1.7 million of income from investments held in the Trust Account, offset by approximately $3.1 million of general and administrative expenses, and $135,000 of general and administrative expenses to related party.

 

We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

 

Going Concern, Liquidity and Capital Resources

 

As of September 30, 2023, we had approximately $222,000 of cash in our operating bank account and a working capital deficit of approximately $6.8 million.

 

Our liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from our Sponsor to cover for certain offering costs on our behalf in exchange for the issuance of Founder Shares, and loan proceeds of $131,517 under a promissory note with the Sponsor. We repaid this promissory note in full on November 15, 2021. Our liquidity needs have otherwise been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement. In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement units at a price of $10.00 per unit.

 

On June 15, 2022, the Company issued a promissory note for a Working Capital Loan, as described above, of $1,500,000 to the Sponsor for the Sponsor to provide additional working capital to the Company on an as-needed basis toward the consummation of a Business Combination. The note was amended effective June 29, 2023 to increase the maximum principal amount to $3,000,000. Proceeds from the Trust Account may only be used to pay off outstanding working capital loans under this promissory note upon the closing of the Business Combination. The Sponsor Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor, all or any portion of the Sponsor Note may be converted into units of the Company upon the consummation of an initial Business Combination (the “Conversion Units”), equal to (x) the portion of the principal amount of the Sponsor Note being converted, divided by (y) $10.00. The Conversion Units are identical to the Private Placement Units issued by the Company to the Sponsor in connection with the Company’s Initial Public Offering. As of September 30, 2023 the Company has drawn down a total of $1,767,244 and still can borrow up $1,232,756 on the Sponsor Note.

 

In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” we have until May 15, 2024 to consummate a Business Combination. We do not have adequate liquidity to sustain operations, however, we have access to a Working Capital Loan from our Sponsor that management believes will enable us to sustain operations until we complete our initial Business Combination. If a Business Combination is not consummated by May 15, 2024, there will be a mandatory liquidation and subsequent dissolution of our Company. Management has determined that the liquidity issue and the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after May 15, 2024. We intend to complete a Business Combination before the mandatory liquidation date. However, there can be no assurance that we will be able to consummate any Business Combination by May 15, 2024.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

 

26

 

 

Commitments and Contractual Obligations

 

As of September 30, 2023, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

 

Administrative Services Agreement

 

Commencing on the date of the Initial Public Offering, we entered into an agreement to pay our Sponsor a total of $15,000 per month for secretarial and administrative services and office space provided to members of our management team. Upon completion of the Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Our Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.

 

Underwriting Agreement

 

On November 9, 2021, we granted the underwriters a 45-day option to purchase up to 3,915,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. In connection with the Initial Public Offering, the underwriters exercised the over-allotment option for 3,900,000 Units and forfeited the remaining 15,000 Units.

 

The underwriters earned an underwriting commission of $0.55 per Unit and $0.55 per Over-Allotment Unit, or $16,500,000 in the aggregate, of which $5,220,000 was paid upon the closing of the Initial Public Offering. The representatives of the underwriters agreed to defer underwriting commissions of 3.5% of the gross proceeds of the Initial Public Offering and 5.5% of the gross proceeds from the partial exercise of the over-allotment option. Upon and concurrently with the completion of our initial business combination, $11,280,000, which constitutes the underwriters’ deferred commissions will be paid to the underwriters from the funds held in the Trust Account.

 

The Company entered into an amended agreement with one of its underwriters (Cantor Fitzgerald) to reduce the amount of deferred underwriting fees associated with the Qenta Business Combination. Upon the successful completion of the Qenta Business Combination, the $6,800,000 deferred underwriting owed to Cantor Fitzgerald will be reduced by $3,400,000.

 

Forward Purchase Agreement

 

In connection with the Business Combination Agreement, we entered into the Forward Purchase Agreement as more fully described in the Business Combination section and Note 6 to the condensed consolidated financial statements.

 

Critical Accounting Estimates

 

The preparation of condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. Excluding the valuation of derivative liabilities and convertible note -related party, we have not identified any critical accounting estimates.

 

Recent Accounting Standards

 

In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-03, Accounting Standards Codification (“ASC”) Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement.

 

27

 

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its condensed consolidated financial statements.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed consolidated financial statements.

 

JOBS Act

 

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our chief executive officer and chief financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023. Based upon their evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

28

 

 

PART II-OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits.

 

No.   Description of Exhibit
   
10.1   Amendment No. 1 to Business Combination Agreement, dated August 22, 2023, by and among Blockchain Coinvestors Acquisition Corp. I, BCSA Merger Sub, Inc. and Qenta Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 001-41050) filed on August 30, 2023).
10.2   Amendment No. 2 to Business Combination Agreement, dated August 29, 2023, by and among Blockchain Coinvestors Acquisition Corp. I, BCSA Merger Sub, Inc. and Qenta Inc. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K (File No. 001-41050) filed on August 30, 2023).
10.3   Amendment No.1 to Sponsor Letter Agreement, dated August 22, 2023, by and among Blockchain Coinvestors Acquisition Corp. I, Blockchain Coinvestors Acquisition Sponsors I LLC and Qenta Inc. (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K (File No. 001-41050) filed on August 30, 2023).
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) or 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) or 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover page formatted as Inline XBRL and contained in Exhibit 101.

 

* Filed herewith.
** Furnished herewith.

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BLOCKCHAIN COINVESTORS ACQUISITION CORP. I
     
Date: November 14, 2023 By:

/s/ Lou Kerner

    Lou Kerner
   

Chief Executive Officer and Director

(Principal Executive Officer)

     
  By:

/s/ Mitchell Mechigian

    Mitchell Mechigian
   

Chief Financial Officer

(Principal Accounting Officer)

 

 

30

 

31322000 31322000 4915271 8784389 0.01 0.03 0.04 0.20 10000000 10000000 10000000 10000000 0.01 0.03 0.04 0.20 10000000 10000000 10000000 10000000 31322000 31322000 4915271 8784389 0.01 0.01 0.03 0.03 0.04 0.04 0.20 0.20 false --12-31 Q3 0001873441 0001873441 2023-01-01 2023-09-30 0001873441 bcsa:UnitsEachConsistingOfOneClassAOrdinaryShareParValue00001PerShareAndOnehalfOfOneRedeemableWarrantMember 2023-01-01 2023-09-30 0001873441 bcsa:ClassAOrdinarySharesParValue00001PerShareMember 2023-01-01 2023-09-30 0001873441 bcsa:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2023-01-01 2023-09-30 0001873441 us-gaap:CommonClassAMember 2023-11-14 0001873441 us-gaap:CommonClassBMember 2023-11-14 0001873441 2023-09-30 0001873441 2022-12-31 0001873441 us-gaap:CommonClassAMember 2023-09-30 0001873441 us-gaap:CommonClassAMember 2022-12-31 0001873441 us-gaap:CommonClassBMember 2023-09-30 0001873441 us-gaap:CommonClassBMember 2022-12-31 0001873441 2023-07-01 2023-09-30 0001873441 2022-07-01 2022-09-30 0001873441 2022-01-01 2022-09-30 0001873441 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001873441 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001873441 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001873441 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001873441 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001873441 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001873441 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001873441 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001873441 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001873441 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001873441 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001873441 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001873441 us-gaap:RetainedEarningsMember 2022-12-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001873441 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001873441 2023-01-01 2023-03-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001873441 us-gaap:RetainedEarningsMember 2023-03-31 0001873441 2023-03-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001873441 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001873441 2023-04-01 2023-06-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001873441 us-gaap:RetainedEarningsMember 2023-06-30 0001873441 2023-06-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001873441 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001873441 us-gaap:RetainedEarningsMember 2023-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001873441 us-gaap:RetainedEarningsMember 2021-12-31 0001873441 2021-12-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001873441 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001873441 2022-01-01 2022-03-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001873441 us-gaap:RetainedEarningsMember 2022-03-31 0001873441 2022-03-31 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001873441 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001873441 2022-04-01 2022-06-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001873441 us-gaap:RetainedEarningsMember 2022-06-30 0001873441 2022-06-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001873441 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001873441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001873441 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001873441 us-gaap:RetainedEarningsMember 2022-09-30 0001873441 2022-09-30 0001873441 us-gaap:IPOMember 2021-11-15 2021-11-15 0001873441 us-gaap:IPOMember 2021-11-15 0001873441 us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001873441 us-gaap:CommonClassAMember 2021-11-15 0001873441 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001873441 us-gaap:PrivatePlacementMember 2023-09-30 0001873441 bcsa:BlockchainCoinvestorsAcquisitionCorpMember 2023-09-30 0001873441 2021-11-15 2021-11-15 0001873441 2021-11-15 0001873441 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-09-30 0001873441 bcsa:BusinessCombinationMember 2023-01-01 2023-09-30 0001873441 bcsa:SponsorMember us-gaap:CommonClassBMember 2023-08-24 0001873441 bcsa:SponsorMember us-gaap:CommonClassAMember 2023-08-24 0001873441 bcsa:SponsorMember 2023-01-01 2023-09-30 0001873441 bcsa:SponsorMember 2023-09-30 0001873441 srt:MinimumMember bcsa:SponsorMember 2022-06-15 0001873441 srt:MaximumMember bcsa:SponsorMember 2022-06-15 0001873441 bcsa:PublicWarrantsMember us-gaap:CommonClassAMember 2021-11-15 2021-11-15 0001873441 bcsa:SponsorMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-09-30 0001873441 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001873441 2021-07-02 2021-07-02 0001873441 bcsa:SponsorMember 2021-07-02 0001873441 us-gaap:CommonClassBMember bcsa:FounderSharesMember 2021-07-02 2021-07-02 0001873441 2021-11-09 0001873441 us-gaap:OverAllotmentOptionMember 2021-11-01 2021-11-09 0001873441 bcsa:FounderSharesMember 2021-11-01 2021-11-09 0001873441 bcsa:PromissoryNoteMember 2021-07-02 2021-07-02 0001873441 2022-06-15 0001873441 bcsa:SponsorMember 2022-06-15 0001873441 bcsa:SponsorMember 2022-06-15 0001873441 bcsa:SponsorMember 2022-12-31 0001873441 bcsa:SponsorMember 2022-01-01 2022-12-31 0001873441 us-gaap:ConvertibleDebtMember 2022-12-31 0001873441 bcsa:SponsorMember 2023-09-30 0001873441 2022-01-01 2022-12-31 0001873441 bcsa:UnderwriterCommitmentToCoverOverAllotmentsMember bcsa:UnitsMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001873441 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-09-30 0001873441 bcsa:CantorFitzgeraldMember 2023-01-01 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember 2023-01-01 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember bcsa:NewQentaCommonStockMember 2023-09-30 0001873441 bcsa:NewQentaCommonStockMember 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember 2023-09-30 0001873441 bcsa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-01-01 2023-09-30 0001873441 bcsa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-09-30 0001873441 bcsa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001873441 us-gaap:SubsequentEventMember 2023-10-01 2023-10-27 0001873441 bcsa:SponsorMember 2023-01-01 2023-09-30 0001873441 bcsa:TrusteesMember 2023-09-30 0001873441 2023-01-31 2023-01-31 0001873441 bcsa:NonredemptionAgreementsMember 2023-09-30 0001873441 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001873441 us-gaap:CommonClassBMember 2021-07-02 0001873441 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-07-01 2021-07-02 0001873441 us-gaap:CommonClassBMember 2021-11-09 2021-11-09 0001873441 us-gaap:CommonClassBMember 2021-11-09 0001873441 2021-11-09 2021-11-09 0001873441 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001873441 us-gaap:CommonClassBMember 2021-11-15 0001873441 bcsa:PublicWarrantsMember 2023-09-30 0001873441 bcsa:PublicWarrantsMember 2022-12-31 0001873441 us-gaap:PrivatePlacementMember 2022-12-31 0001873441 bcsa:PublicWarrantsMember 2023-01-01 2023-09-30 0001873441 us-gaap:CommonClassAMember bcsa:PublicWarrantsMember 2023-01-01 2023-09-30 0001873441 bcsa:PrivatePlacementWarrantsMember 2023-09-30 0001873441 bcsa:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001873441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001873441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001873441 bcsa:ForwardPurchaseAgreementMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001873441 us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001873441 us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001873441 us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001873441 us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001873441 us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-09-30 0001873441 us-gaap:MeasurementInputPriceVolatilityMember 2022-01-01 2022-12-31 0001873441 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-09-30 0001873441 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-01-01 2022-12-31 0001873441 us-gaap:MeasurementInputExpectedDividendRateMember 2023-01-01 2023-09-30 0001873441 us-gaap:MeasurementInputExpectedDividendRateMember 2022-01-01 2022-12-31 0001873441 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001873441 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001873441 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001873441 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001873441 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001873441 us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001873441 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001873441 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001873441 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001873441 2023-10-27 0001873441 us-gaap:SubsequentEventMember bcsa:SponsorMember 2023-10-01 2023-10-27 0001873441 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2023-10-01 2023-10-27 0001873441 us-gaap:SubsequentEventMember 2023-10-27 0001873441 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2023-10-27 0001873441 us-gaap:SubsequentEventMember 2023-11-08 2023-11-08 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Lou Kerner, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Blockchain Coinvestors Acquisition Corp. I;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023

/s/ Lou Kerner

  Lou Kerner
  Chief Executive Officer
  (Principal Executive Officer)

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Mitchell Mechigian, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Blockchain Coinvestors Acquisition Corp. I;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023

/s/ Mitchell Mechigian

  Mitchell Mechigian
  Chief Financial Officer
  (Principal Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of Blockchain Coinvestors Acquisition Corp. I (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lou Kerner, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023 By:

/s/ Lou Kerner

    Lou Kerner
   

Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of Blockchain Coinvestors Acquisition Corp. I (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mitchell Mechigian, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023 By:

/s/ Mitchell Mechigian

    Mitchell Mechigian
    Chief Financial Officer
    (Principal Accounting Officer)

 

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Document Information Line Items    
Entity Registrant Name BLOCKCHAIN COINVESTORS ACQUISITION CORP. I  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001873441  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity Incorporation, State or Country Code E9  
Entity File Number 001-41050  
Entity Tax Identification Number 98-1607883  
Entity Address, Address Line One PO Box 1093, Boundary Hall  
Entity Address, Address Line Two Cricket Square  
Entity Address, City or Town Grand Cayman  
Entity Address, Postal Zip Code KY1-1102  
Entity Address, Country KY  
City Area Code (345)  
Local Phone Number 814-5726  
Entity Interactive Data Current Yes  
Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant    
Document Information Line Items    
Trading Symbol BCSAU  
Title of 12(b) Security Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant  
Security Exchange Name NASDAQ  
Class A ordinary shares, par value $0.0001 per share    
Document Information Line Items    
Trading Symbol BCSA  
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50    
Document Information Line Items    
Trading Symbol BCSAW  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50  
Security Exchange Name NASDAQ  
Class A Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   13,433,794
Class B Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   0
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 222,456 $ 254,781
Prepaid expenses 63,224 384,630
Total current assets 285,680 639,411
Investments held in Trust Account 39,041,590 310,263,214
Total Assets 39,327,270 310,902,625
Current liabilities:    
Accounts payable 4,944,332 3,704,441
Convertible promissory note – related party, fair value 525,824 525,824
Convertible promissory note – related party, par value 1,241,420
Accrued expenses 328,294 320,516
Total current liabilities 7,039,870 4,550,781
Derivative liabilities 1,052,424 1,581,227
Deferred underwriting commissions in connection with the initial public offering 11,280,000 11,280,000
Total Liabilities 19,372,294 17,412,008
Commitments and Contingencies
Shareholders’ Deficit:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022
Additional paid-in capital
Accumulated deficit (18,987,646) (16,673,629)
Total shareholders’ deficit (18,986,614) (16,672,597)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit 39,327,270 310,902,625
Class A Ordinary Shares    
Current liabilities:    
Class A ordinary shares subject to possible redemption; $0.0001 par value; 3,593,271 and 30,000,000 shares at redemption value of approximately $10.84 and $10.34 per share as of September 30, 2023 and December 31, 2022, respectively 38,941,590 310,163,214
Shareholders’ Deficit:    
Ordinary shares value 132 132
Class B Ordinary Shares    
Shareholders’ Deficit:    
Ordinary shares value $ 900 $ 900
v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Preference shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preference shares, shares authorized 5,000,000 5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Ordinary shares, shares issued 4,915,271 31,322,000
Ordinary shares, shares outstanding 4,915,271 31,322,000
Class A Ordinary Shares    
Ordinary shares subject to possible redemption, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares subject to possible redemption, shares at redemption value 3,593,271 30,000,000
Ordinary shares subject to possible redemption, per share (in Dollars per share) $ 10.84 $ 10.34
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 500,000,000 500,000,000
Ordinary shares, shares issued 1,322,000 1,322,000
Ordinary shares, shares outstanding 1,322,000 1,322,000
Class B Ordinary Shares    
Ordinary shares, par value (in Dollars per share) $ 0.00009 $ 0.00009
Ordinary shares, shares authorized 50,000,000 50,000,000
Ordinary shares, shares issued 10,000,000 10,000,000
Ordinary shares, shares outstanding 10,000,000 10,000,000
v3.23.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
General and administrative expenses $ 355,310 $ 1,174,367 $ 2,735,330 $ 3,088,036
Loss from operations (383,981) (1,219,367) (2,842,820) (3,223,036)
Other income:        
Change in fair value of derivative liabilities 189,498 117,457 255,274 9,827,277
Change in fair value of forward purchase agreement 127,957 273,529
Income earned on investments held in Trust Account 502,059 1,533,315 2,986,102 1,679,514
Total Other income 819,514 1,650,772 3,514,905 11,506,791
Net income $ 435,533 $ 431,405 $ 672,085 $ 8,283,755
Class A Ordinary Shares        
Other income:        
Weighted average number of shares outstanding, basic (in Shares) 4,915,271 31,322,000 8,784,389 31,322,000
Basic, net income per share (in Dollars per share) $ 0.03 $ 0.01 $ 0.04 $ 0.2
Class B Ordinary Shares        
Other income:        
Weighted average number of shares outstanding, basic (in Shares) 10,000,000 10,000,000 10,000,000 10,000,000
Basic, net income per share (in Dollars per share) $ 0.03 $ 0.01 $ 0.04 $ 0.2
Related Party        
General and administrative expenses - related party $ 28,671 $ 45,000 $ 107,490 $ 135,000
v3.23.3
Unaudited Condensed Consolidated Statements of Operations (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Ordinary Shares        
Weighted average number of shares outstanding , Diluted 4,915,271 31,322,000 8,784,389 31,322,000
Diluted, net income per share $ 0.03 $ 0.01 $ 0.04 $ 0.20
Class B Ordinary Shares        
Weighted average number of shares outstanding , Diluted 10,000,000 10,000,000 10,000,000 10,000,000
Diluted, net income per share $ 0.03 $ 0.01 $ 0.04 $ 0.20
v3.23.3
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 132 $ 900 $ (21,859,293) $ (21,858,261)
Balance (in Shares) at Dec. 31, 2021 1,322,000 10,000,000      
Net income (loss) 4,313,808 4,313,808
Balance at Mar. 31, 2022 $ 132 $ 900 (17,545,485) (17,544,453)
Balance (in Shares) at Mar. 31, 2022 1,322,000 10,000,000      
Balance at Dec. 31, 2021 $ 132 $ 900 (21,859,293) (21,858,261)
Balance (in Shares) at Dec. 31, 2021 1,322,000 10,000,000      
Net income (loss)         8,283,755
Balance at Sep. 30, 2022 $ 132 $ 900 (15,156,142) (15,155,110)
Balance (in Shares) at Sep. 30, 2022 1,322,000 10,000,000      
Balance at Mar. 31, 2022 $ 132 $ 900 (17,545,485) (17,544,453)
Balance (in Shares) at Mar. 31, 2022 1,322,000 10,000,000      
Increase in redemption value of Class A ordinary shares subject to possible redemption (47,289) (47,289)
Net income (loss) 3,538,542 3,538,542
Balance at Jun. 30, 2022 $ 132 $ 900 (14,054,232) (14,053,200)
Balance (in Shares) at Jun. 30, 2022 1,322,000 10,000,000      
Increase in redemption value of Class A ordinary shares subject to possible redemption (1,533,315) (1,533,315)
Net income (loss) 431,405 431,405
Balance at Sep. 30, 2022 $ 132 $ 900 (15,156,142) (15,155,110)
Balance (in Shares) at Sep. 30, 2022 1,322,000 10,000,000      
Balance at Dec. 31, 2022 $ 132 $ 900 (16,673,629) (16,672,597)
Balance (in Shares) at Dec. 31, 2022 1,322,000 10,000,000      
Shareholder non-redemption agreements 155,250 155,250
Shareholder non-redemption agreements (155,250) (155,250)
Increase in redemption value of Class A ordinary shares subject to possible redemption (2,028,239) (2,028,239)
Net income (loss) (479,264) (479,264)
Balance at Mar. 31, 2023 $ 132 $ 900 (19,181,132) (19,180,100)
Balance (in Shares) at Mar. 31, 2023 1,322,000 10,000,000      
Balance at Dec. 31, 2022 $ 132 $ 900 (16,673,629) (16,672,597)
Balance (in Shares) at Dec. 31, 2022 1,322,000 10,000,000      
Net income (loss)         672,085
Balance at Sep. 30, 2023 $ 132 $ 900 (18,987,646) (18,986,614)
Balance (in Shares) at Sep. 30, 2023 1,322,000 10,000,000      
Balance at Mar. 31, 2023 $ 132 $ 900 (19,181,132) (19,180,100)
Balance (in Shares) at Mar. 31, 2023 1,322,000 10,000,000      
Increase in redemption value of Class A ordinary shares subject to possible redemption (455,804) (455,804)
Net income (loss) 715,816 715,816
Balance at Jun. 30, 2023 $ 132 $ 900 (18,921,120) (18,920,088)
Balance (in Shares) at Jun. 30, 2023 1,322,000 10,000,000      
Increase in redemption value of Class A ordinary shares subject to possible redemption (502,059) (502,059)
Net income (loss) 435,533 435,533
Balance at Sep. 30, 2023 $ 132 $ 900 $ (18,987,646) $ (18,986,614)
Balance (in Shares) at Sep. 30, 2023 1,322,000 10,000,000      
v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income $ 672,085 $ 8,283,755
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (255,274) (9,827,277)
Change in fair value of forward purchase agreement (273,529)
Income earned on investments held in Trust Account (2,986,102) (1,679,514)
Changes in operating assets and liabilities:    
Prepaid expenses 321,406 244,802
Accounts payable 1,239,891 155,843
Accrued expenses 7,778 2,387,500
Net cash used in operating activities (1,273,745) (434,891)
Cash Flows from Investing Activities:    
Cash withdrawn from trust account for redemptions 274,207,726
Net cash provided by investing activities 274,207,726
Cash Flows from Financing Activities:    
Proceeds from note payable to related party 1,241,420 170,000
Offering costs paid (30,000)
Redemption of Class A Ordinary Shares (274,207,726)
Net cash (used in) provided by financing activities (272,966,306) 140,000
Net change in cash (32,325) (294,891)
Cash - beginning of the period 254,781 380,035
Cash - end of the period $ 222,456 $ 85,144
v3.23.3
Organization and Business Operations
9 Months Ended
Sep. 30, 2023
Organization and Business Operations [Abstract]  
Organization and Business Operations

Note 1 — Organization and Business Operations

 

Blockchain Coinvestors Acquisition Corp. I (the “Company”) was incorporated as a Cayman Islands exempted company on June 11, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activity for the period from June 11, 2021 (inception) through September 30, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

 

The Company’s sponsor is Blockchain Coinvestors Acquisition Sponsors I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 9, 2021 (the “Effective Date”). On November 15, 2021, the Company commenced the Initial Public Offering of 30,000,000 units (the “Units”) at $10.00 per unit, including the issuance of 3,900,000 Units as a result of the underwriters’ partial exercise of the over-allotment option, which is discussed in Note 4. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

 

Simultaneously with the consummation of the Initial Public Offering and partial exercise of the over-allotment option by the underwriters, the Company consummated the private placement of 1,322,000 units (the “Private Placement Units”) with the Sponsor, at a price of $10.00 per Private Placement Unit. Transaction costs amounted to $17,800,002, consisting of $5,220,000 of underwriting commissions, $11,280,000 of deferred underwriting commissions, and $1,300,002 of other offering costs.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding any deferred underwriters’ commission and taxes payable on the interest income earned on the Trust Account at the time of the Company’s signing of a definitive agreement in connection with the initial Business Combination) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

 

Following the closing of the Initial Public Offering and partial exercise of the over-allotment by the underwriters on November 15, 2021, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was deposited into a trust account (the “Trust Account”) and were subsequently invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company intends to maintain trust funds only in demand deposit accounts after November 15, 2023.

 

The Company will provide holders of its Class A ordinary shares, par value $0.0001, originally sold in the Initial Public Offering (the “Public Shares” and such holders, the “Public Shareholders”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement. Asset acquisitions and share purchases would not typically require shareholder approval, while direct mergers with the Company where the Company does not survive and any transactions, where the Company issues more than 20% of the outstanding ordinary shares or seek to amend its memorandum and articles of association would typically require shareholder approval. The Company currently intends to conduct redemptions in connection with a shareholder vote unless shareholder approval is not required by applicable law or stock exchange listing requirements or the Company chooses to conduct redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) for business or other reasons. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).

 

Notwithstanding the foregoing, the Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares originally sold in the Initial Public Offering, without the prior consent of the Company.

 

The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the time period set forth in its Amended and Restated Memorandum and Articles of Association, as may be amended from time to time or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

 

The Company had 18 months from the closing of the Initial Public Offering to consummate the initial Business Combination, which has been subsequently extended to May 15, 2024 (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and the Combination Period is not further extended, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor and each member of the Company’s management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to the ordinary shares of the Company that they received in connection with the Company's initial public offering in connection with the completion of a Business Combination; (ii) waive their redemption rights with respect to the ordinary shares that they received in connection with the Company's initial public offering in connection with a shareholder vote to approve an amendment to the Company’s Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares; and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their ordinary shares of the Company that they received in connection with the Company's initial public offering if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

Business Combination

 

On November 10, 2022, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among the Company, BCSA Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Qenta Inc., a Delaware corporation (“Qenta”).

 

The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Qenta. The Business Combination Agreement provides for, among other things, the following transactions: (i) the Company would become a Delaware corporation (the “Domestication”) and, in connection with the Domestication, (A) the Company’s name would be changed to “Qenta Inc.” (“New Qenta”) and (B) each outstanding ordinary share of the Company will become one share of common stock of New Qenta (the “New Qenta Common Stock”); and (ii) following the Domestication, Merger Sub would merge with and into Qenta, with Qenta as the surviving company in the merger and continuing as a wholly owned subsidiary of New Qenta (the “Merger”).

 

The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are referred to as the “Qenta Business Combination.

 

On August 24, 2023, the Company, Merger Sub, and Qenta entered into an amendment (the “First BCA Amendment”) to the Business Combination agreement, to, among other things, extend the Termination Date (as defined in the Business Combination Agreement) until May 15, 2024. In addition, under the terms of the First BCA Amendment, Qenta agreed to deliver to the Company specified financial statements and other financial information by specified deadlines (the “Financial Information Obligations”), and the Company agreed not to exercise, but did not waive, BCSA’s Financial Statement Termination Right (as defined in the Business Combination Agreement) unless Qenta failed to comply with the Financial Information Obligations.  Qenta failed to meet the first specified Financial Information Obligations deadline.

 

On August 29, 2023, the Company, Merger Sub, and Qenta entered into a second amendment (the “Second BCA Amendment”) to the Business Combination Agreement to eliminate the exclusive dealing provision applicable to the Company and to limit the exclusive dealing provision applicable to Qenta to transactions involving special purpose acquisition companies and similar “blank check” companies.

 

On August 24, 2023, the Company, Sponsor and Qenta entered into an amendment (the “Sponsor Letter Amendment”) to the Sponsor Letter Agreement, dated as of November 10, 2022, by and among the Company, the Sponsor and Qenta, pursuant to which the Sponsor agreed, in connection with the completion of a financing transaction between Qenta and financing parties, to transfer and assign, contingent and conditioned upon the closing of the transactions contemplated by the Business Combination Agreement, up to 3,178,000 of the Sponsor’s Class B ordinary shares of the Company (or, if converted, Class A ordinary shares) and 1,322,000 of the Sponsor’s private placement units of the Company to such financing parties or to Qenta in such amounts and proportions as designated by Qenta, provided that all transferees of such shares or units, as applicable, execute and deliver to the Company a lockup agreement in respect of such securities.

 

In connection with the execution of the Business Combination Agreement, the Company entered into a Confirmation (the “Forward Purchase Agreement”), with Vellar Opportunity Fund SPV LLC—Series 5 (the “FPA Seller”), a client of Cohen & Company Financial Management, LLC (“Cohen”). Entities and funds managed by Cohen own equity interests in the Sponsor. The primary purpose of entering into the Forward Purchase Agreement was to help ensure the aggregate cash proceeds condition in the Business Combination Agreement would be met, increasing the likelihood that the transaction would close. Pursuant to the Forward Purchase Agreement, (a) the FPA Seller could have, but was not obligated to, purchase after the date of the Company’s redemption deadline through a broker in the open market the Company’s Class A ordinary shares, including such shares that holders had elected to redeem pursuant to the Company’s organizational documents in connection with the Qenta Business Combination, other than from the Company or affiliates of the Company, and (b) the FPA Seller agreed to waive any redemption rights in connection with the Qenta Business Combination with respect to such Class A ordinary shares of the Company it purchased in accordance with the Forward Purchase Agreement (the “Subject Shares”). See Note 6 where the Forward Purchase Agreement is more fully described.

 

On November 8, 2023, the Company delivered to Qenta written notice of its election to terminate the Business Combination Agreement pursuant to Section 7.1(h) thereof, and abandoned the Qenta Business Combination.

 

In conjunction with the termination of the Business Combination Agreement, the Lock-up Agreements, Sponsor Letter Agreement, Transaction Support Agreements and Forward Purchase Agreement were also terminated in accordance with their respective terms.

 

The full Business Combination Agreement, Forward Purchase Agreement, related amendments and other agreements entered into or contemplated to be executed prior to closing the Qenta Business Combination were included with the Company’s Current Reports on Form 8-K filed with the SEC on November 10, 2022 and August 30, 2023.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make the comparison of the Company’s condensed consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Going Concern, Liquidity and Capital Resources

 

As of September 30, 2023, the Company had approximately $222,000 in its operating bank account and working capital deficit of approximately $6.8 million, inclusive of convertible note payable – related party of approximately $1.8 million.

 

The Company’s liquidity needs up to September 30, 2023 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares (as defined in Note 5) to cover certain offering costs and through the loan under an unsecured promissory note from the Sponsor of $131,517 (see Note 5) and the proceeds from the consummation of the Private Placement not held in the Trust Account. The promissory note was paid in full on November 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, initial shareholders, officers, directors or their affiliates may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). On June 15, 2022, the Company issued a promissory note (the “Sponsor Note”) in the principal amount of up to $1,500,000 to the Sponsor, which was amended effective June 2023 to increase the maximum principal amount to $3,000,000 (see Note 5). As of September 30, 2023, the Company has drawn down a total of $1,767,244 and still can borrow up $1,232,756 on the Sponsor Note.

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until May 15, 2024 to consummate a Business Combination. The Company does not have adequate liquidity to sustain operations; however, the Company has access to a Working Capital Loan from the Sponsor that management believes will enable the Company to sustain operations until it completes its initial Business Combination. If a Business Combination is not consummated by May 15, 2024, and such deadline to consummate a Business Combination is not further extended, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the Company’s liquidity issue, mandatory liquidation should a Business Combination not occur by the applicable deadline, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 15, 2024. There can be no assurance that the Company will be able to consummate any Business Combination by May 15, 2024.

 

Risks and Uncertainties

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed unaudited consolidated financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed consolidated financial statements.

 

On May 1, 2023, First Republic Bank became insolvent. Federal regulators seized the assets of the bank and negotiated a sale of its assets to JP Morgan Chase. The Company held deposits with this bank. As a result of the sale of the assets to JP Morgan Chase, the Company’s insured and uninsured deposits are held at JP Morgan Chase. The Company also moved the funds held in trust for the shareholders and invested in federal government securities through Morgan Stanley.

v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Significant Accounting Policies

Note 2 — Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023, or any future period.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 17, 2023.

 

Principles of Consolidation

 

The unaudited condensed consolidated financial statements of the Company include its wholly owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in the accompanying unaudited condensed consolidated financial statements is the determination of the fair value of derivative warrant liabilities. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2023 and December 31, 2022.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income earned on investments held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Convertible Promissory Note —Related Party, Fair Value

 

The Company entered into a convertible promissory note with its Sponsor on June 15, 2022. The Company has elected the fair value option to account for proceeds received during 2022. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Fair Value.” The primary reason for electing the fair value option in the 2022 proceeds is to provide better information on the financial liability amount given current market and economic conditions of the Company. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value recorded as change in the fair value of convertible note—related party on the accompanying unaudited condensed consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.

 

Convertible Promissory Note —Related Party, Par Value

 

The Company has elected the bifurcated option to account for proceeds received during 2023 from the Convertible promissory notes with its Sponsor on June 2023. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Par Value.”

 

The Company analyzed the Convertible Promissory Note – Related Party to assess if the fair value option was appropriate in 2023, due to the substantial premium which results in an offsetting entry to additional paid in capital and under the related party guidance which precludes the fair value option it was determined the fair value option was not appropriate. As such, the Company accounted for the Convertible Promissory Note – Related Party, Par Value, analyzing the conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.

 

The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

 

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as nonoperating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.

 

It was determined that the previous conversion option was de minimis, as such the Company has recorded the Convertible Promissory Note – Related Party at par value through the rest of the note’s use.

 

Derivative Liabilities

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants was estimated using a stochastic trinomial tree model. The determination of the fair value of the warrants may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

The Company determined the Forward Purchase Agreement (defined in Note 1) is a derivative instrument. Accordingly, the Company recognizes the instrument as an asset or liability at fair value and adjusts the instrument to fair value at each reporting period. Any changes in fair value are recognized on the Company’s unaudited condensed consolidated statements of operations. The estimated fair value of the Forward Purchase Agreement is measured at fair value utilizing a Monte Carlo simulation model.

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. As part of the Private Placement, the Company issued 1,322,000 Class A ordinary shares to the Sponsor (“Private Placement Shares”). These Private Placement Shares will not be transferable, assignable or saleable until 30 days after the completion of the initial Business Combination, as such they are considered non-redeemable and presented as permanent equity in the Company’s condensed consolidated balance sheets. Excluding the Private Placement Shares, the Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 3,593,271 and 30,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed consolidated balance sheets, respectively.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in redemption value of Class A ordinary shares subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.

 

Income Taxes

 

The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

 

Net Income per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.

 

The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 15,661,000 Class A ordinary shares because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

 

The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each period presented:

 

   For the Three Months Ended September 30,   For the Nine months Ended September 30, 
   2023   2022   2023   2022 
   Class A   Class B   Class A   Class B   Class A   Class B   Class A   Class B 
Basic and diluted net income per ordinary share:                                
Numerator:                                
Allocation of net income  $143,528   $292,005   $327,004   $104,401   $314,296   $357,789   $6,279,071   $2,004,684 
Denominator:                                        
Basic and diluted weighted average ordinary shares outstanding
   4,915,271    10,000,000    31,322,000    10,000,000    8,784,389    10,000,000    31,322,000    10,000,000 
Basic and diluted net income per ordinary share
  $0.03   $0.03   $0.01   $0.01   $0.04   $0.04   $0.20   $0.20 

 

Recent Accounting Standards

 

In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its condensed consolidated financial statements.

 

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

v3.23.3
Initial Public Offering
9 Months Ended
Sep. 30, 2023
Initial Public Offering [Abstract]  
Initial Public Offering

Note 3 — Initial Public Offering

 

On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 Units from the partial exercise of over-allotment option at a purchase price of $10.00 per Unit. Each Unit that the Company offered had a price of $10.00 and consisted of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9).

 

Following the closing of the Initial Public Offering and the partial exercise of the over-allotment by the underwriters on November 15, 2021, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units, was placed in a Trust Account.

v3.23.3
Private placement
9 Months Ended
Sep. 30, 2023
Private Placement [Abstract]  
Private Placement

Note 4 — Private Placement

 

Simultaneously with the closing of the Initial Public Offering and partial exercise of the over-allotment option by the underwriters, the Company’s Sponsor purchased an aggregate of 1,322,000 Private Placement Units, at a price of $10.00 per Unit, or $13,220,000 in the aggregate, in a private placement.

 

Each Private Placement Unit consists of one share of Class A ordinary share and one-half of one warrant (the “Private Placement Warrant”). Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable except as described below in Note 9 and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

 

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination or 12 months from the closing of the Initial Public Offering.

v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 — Related Party Transactions

 

Founder Shares

 

On July 2, 2021, the Sponsor paid $25,000, or approximately $0.003 per share, in consideration for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). Effective November 9, 2021, the Company effected a stock split and a stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which were subject to forfeiture if the over-allotment option were not exercised in full or in part by the underwriters. At the Initial Public Offering, the underwriters partially exercised their over-allotment option resulting in 5,000 Founder Shares being forfeited, such that the Founder Shares represented approximately 25% of the Company’s issued and outstanding shares after the Initial Public Offering (excluding Private Placement Shares), and 1,300,000 shares no longer being subject to forfeiture.

 

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.

 

Promissory Note—Related Party

 

On July 2, 2021, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of September 30, 2022 or the completion of the Initial Public Offering. The aggregate amount of $131,517 was paid in full on November 15, 2021 upon closing of the Initial Public Offering. Subsequent to the repayment, the facility was no longer available to the Company.

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement units at a price of $10.00 per unit.

 

Convertible Promissory Notes – Related Party, Fair Value and Par Value

 

On June 15, 2022, the Company issued a promissory note for a Working Capital Loan, as described above, of $1,500,000 to the Sponsor for the Sponsor to provide additional working capital to the Company on an as-needed basis toward the consummation of a Business Combination. The Sponsor Note was amended effective June 29, 2023 to increase the maximum principal amount to $3,000,000. Proceeds from the Trust Account may only be used to pay off outstanding working capital loans under this promissory note upon the closing of the Business Combination. The Sponsor Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor, all or any portion of the Sponsor Note may be converted into units of the Company upon the consummation of an initial Business Combination (the “Conversion Units”), equal to (x) the portion of the principal amount of the Sponsor Note being converted, divided by (y) $10.00. The Conversion Units are identical to the Private Placement Units issued by the Company to the Sponsor in connection with the Company’s Initial Public Offering. As of September 30, 2023, principal in the amount of $1,767,244 was outstanding, leaving $1,232,756 of borrowing capacity under the Sponsor Note.

 

As of September 30, 2023 and December 31, 2022, the portion of the Sponsor Note carried under the fair value method is described as “Convertible Promissory Note – Related Party, Fair Value” on the accompanying condensed consolidated balance sheets with a balance of $525,824, respectively. The 2022 proceeds from principal on the Convertible Promissory Note – Related Party, Fair Value totaled $512,000, and were historically fair valued to the amount of $525,824, containing a $13,824 change in value recorded on the statement of operations for the year ended December 31, 2022. There were no changes in fair value or principal recorded during the period ended September 30, 2023.

 

During the period ended September 30, 2023, the Company has concluded that the fair value of the conversion feature on 2023 proceeds from principal, require bifurcation under ASC 815 and is considered de minimis. The underlying economics of the transaction are more accurately represented by recording this portion of the convertible debt agreement as a liability at par value given the de minimis value of the embedded conversion feature in this case.

 

As of September 30, 2023, a portion of the Sponsor Note carried under the bifurcation method is described as “Convertible Promissory Note – Related Party, Par Value” on the accompanying condensed consolidated balance sheets with a balance of $1,241,420, as of December 31, 2022, the balance was zero. 2023 proceeds from principal on the Convertible Promissory Note – Related Party, Par Value totaled $1,241,420.

 

Administrative Services Agreement

 

Commencing on the date the securities are first listed on Nasdaq, the Company has agreed to pay the Sponsor a total of $15,000 per month for secretarial and administrative support services provided to the Company. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2022, the Company incurred expenses of approximately $45,000 and $135,000, respectively, under this agreement. For the three and nine months ended September 30, 2023, the Company incurred expenses of approximately $28,671 and $107,490 under this agreement, respectively. As of September 30, 2023, and December 31, 2022, approximately $14,900 and approximately $106,000, respectively, were due for administrative services in connection with such agreement and have been included in the accrued expenses of the accompanying unaudited condensed consolidated balance sheets.

 

In addition, the Sponsor, executive officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

Note 6 — Commitments and Contingencies

 

Registration and Shareholder Rights

 

The holders of Founder Shares, Private Placement Warrants and securities included in private placement units that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement entered into in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggyback” registration rights with respect to registration statements filed after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreements and Amendments

 

The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,915,000 Units to cover over-allotments, if any. On November 15, 2021, the underwriters partially exercised the over-allotment and the unexercised portion of the over-allotment of 15,000 units was forfeited. The underwriters were paid underwriting commission of $0.20 per unit, or $5,220,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, $11,280,000 in the aggregate, is payable to the underwriters for deferred underwriting commissions. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

 

The Company entered into an amended agreement with one of its underwriters (Cantor Fitzgerald) to reduce the amount of deferred underwriting fees associated with the Qenta Business Combination. Upon the successful completion of the Qenta Business Combination, the $7,896,000 deferred underwriting fee owed to Cantor Fitzgerald would have been reduced to $3,948,000.

 

Forward Share Purchase Agreement

 

In connection with the execution of the Business Combination Agreement, the Company entered into the Forward Purchase Agreement. Pursuant to the Forward Purchase Agreement, (a) the FPA Seller could have, but was not obligated to, purchase after the date of the Company’s redemption deadline through a broker in the open market the Company’s Class A ordinary shares, including such shares that holders had elected to redeem pursuant to the Company’s organizational documents in connection with the Qenta Business Combination, other than from the Company or affiliates of the Company, and (b) the FPA Seller agreed to waive any redemption rights in connection with the Qenta Business Combination with respect to such Class A ordinary shares of the Company it purchased in accordance with the Forward Purchase Agreement (the “Subject Shares”). The Number of Shares were to equal the Subject Shares but be no more than 12,000,000 Shares. The FPA Seller agreed to not beneficially own more than 9.9% of the New Qenta Common Stock on a post-combination pro forma basis.

 

The Forward Purchase Agreement provided that (a) one business day following the closing of the Qenta Business Combination, New Qenta would pay to the FPA Seller, out of the Trust Account, an amount (the “Prepayment Amount”) equal to the Redemption Price per share (the “Initial Price”) multiplied by the aggregate number of Subject Shares, if any (together, the “Number of Shares”), less 10% (the “Shortfall Amount”) on the date of such prepayment. New Qenta would also deliver the FPA Seller an amount equal to the product of 500,000 multiplied by the Redemption Price to repay the FPA Seller for having purchased up to an additional 500,000 Class A ordinary shares of the Company, which would not be included in the Number of Shares or the Terminated Shares (as defined in the Forward Purchase Agreement).

 

From time to time and on any scheduled trading day after the closing of the Qenta Business Combination, the FPA Seller could have sold Subject Shares or Additional Shares (as defined in the Forward Purchase Agreement) at its absolute discretion in one or more transactions, publicly or privately, and, in connection with such sales, terminate the Forward Purchase Transaction in whole or in part in an amount corresponding to the number of Subject Shares and Additional Shares.

 

The Forward Purchase Agreement had a tenure of 36 months (“Maturity Date”), after which time New Qenta would be required to purchase from the FPA Seller such number of shares equal to the Maximum Number of Shares (as defined in the Forward Purchase Agreement) less the Terminated Shares (as defined in the Forward Purchase Agreement) for consideration, settled in cash or New Qenta Common Stock, equal to the Maturity Consideration, which is the amount of (a) in the case of cash, the product of the Maximum Number of Shares less the Terminated Shares and $1.75 and (b) in the case of New Qenta Common Stock, such number of New Qenta Common Stock with a value equal to the product of the Maximum Number of Shares less the Terminated Shares and $1.75 divided by the VWAP Price of the Shares for the 30 trading days prior to the Maturity Date. In certain circumstances, the Maturity Date could have been accelerated, as described in the Forward Purchase Agreement.

 

The Company and Qenta agreed to pay to the FPA Seller a break-up fee equal to the sum of (i) all fees (in an amount not to exceed $75,000), plus (ii) $350,000, if the Company or Qenta were to terminate the Forward Purchase Agreement prior to the FPA Sellers purchasing shares under the agreement, other than because the Qenta Business Combination did not close, or Class A Ordinary Share redemptions were less than 80%.

 

The primary purpose of entering into the Forward Purchase Agreement was to help ensure the aggregate cash proceeds condition in the Business Combination Agreement would be met, increasing the likelihood that the transaction would close.

 

In conjunction with the termination of the Business Combination Agreement, the Forward Purchase Agreement was terminated in accordance with its terms on November 8, 2023.

 

Shareholder Meetings, Extensions, and Redemptions

 

On February 3, 2023, the Company held an extraordinary general meeting (the “Shareholder Meeting”) at which the Company’s shareholders approved a proposal to amend the Company’s amended and restated memorandum and articles of association (the “Memorandum and Articles of Association”) to extend the date by which it has to consummate a business combination from May 15, 2023 to November 15, 2023 (the “Extension Amendment Proposal”). The Extension Amendment Proposal is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on December 29, 2022.

 

In connection with the vote to approve the Extension Amendment Proposal, holders of 26,406,729 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.38 per share, for an aggregate redemption amount of approximately $274.2 million. As a result, approximately $274.2 million has been removed from the Trust Account to redeem such shares and 4,915,271 Class A ordinary shares remain outstanding after the redemption, including 1,322,000 shares underlying the Private Placement Units. Upon payment of the redemption, approximately $37.3 million remained in the Trust Account.

 

On October 27, 2023, the Company held an extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders (the “Second Shareholder Meeting”) at which the Company shareholders approved proposals to amend the Company’s amended and restated memorandum and articles of association to (i) extend the date by which BCSA must consummate a business combination from November 15, 2023 to May 15, 2024 or such earlier date as may be determined by the Company’s board of directors in its sole discretion (the “Second Extension Amendment Proposal”), (ii) eliminate the limitation that the Company may not redeem its Class A ordinary shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of a business combination (the “Redemption Limitation Amendment Proposal”), and (iii) permit for the issuance of Class A Shares to holders of the Company’s Class B ordinary shares (“Founder Shares”) upon the exercise of the right of a holder of BCSA’s Founder Shares to convert such holder’s Founder Shares into Class A Shares on a one-for-one basis at any time and from time to time prior to the closing of an initial business combination at the election of the holder (the “Founder Share Amendment Proposal,” and together with the Second Extension Amendment Proposal and the Redemption Limitation Amendment Proposal, the “Articles Amendment Proposals”). The Articles Amendment Proposals are described in more detail in BCSA’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 5, 2023.

 

In connection with the approval of the Founder Share Amendment Proposal, the Sponsor voluntarily elected to convert all 9,850,000 of its Founder Shares to Class A Shares, and the independent directors of BCSA voluntarily elected to convert all 150,000 of their Founder Shares to Class A Shares, in each case, on a one-for-one basis in accordance with the Memorandum and Articles of Association (such conversions collectively, the “Founder Share Conversion”). The Sponsor and the independent directors waived any right to receive funds from the trust account established by the Company in connection with its initial public offering with respect to the Class A Shares received upon such conversion and no additional amounts were deposited into the Trust Account in respect of any of those Class A Shares.

 

In connection with the vote to approve the Articles Amendment Proposals, holders of 1,481,477 Class A Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $16.2 million (approximately $10.91 per share) was removed from the Trust Account to redeem such shares. Upon payment of the redemption, and after giving effect to the Founder Share Conversion, BCSA has approximately 13,433,794 Class A Shares outstanding, including 2,111,794 Class A Shares having a right to request redemptions for a pro rata portion of the funds remaining in the Trust Account.

 

Vendor Agreements Contingent on the Business Combination

 

The Company entered into an agreement with a vendor for merger advisory services and the total fee will be $6,200,000, contingent upon completion of the Qenta Business Combination.

 

In January 2023, the Company entered into an agreement with a vendor for investment banking services. The agreement specifies that upon a successful Business Combination, the Company will owe a fee of $1,250,000 which is payable in cash or equity at the Company’s option.

 

Non-redemption Agreements

 

The Sponsor entered into Non-Redemption Agreements with various shareholders of the Company (the “Non-Redeeming Shareholders”), pursuant to which these shareholders agreed not to redeem a portion of their shares of Company common stock (the “Non-Redeemed Shares”) in connection with the Special Meeting held on February 3, 2023, but such shareholders retained their right to require the Company to redeem such Non-Redeemed Shares in connection with the closing of the Business Combination. The Sponsor has agreed to transfer to such Non-Redeeming shareholders an aggregate of 739,286 the Founder Shares held by the Sponsor immediately following the consummation of an initial Business Combination. The Company estimated the aggregate fair value of such 739,286 Founder Shares transferrable to the Non-Redeeming shareholders pursuant to the Non-Redemption Agreement to be $155,250 or $0.21 per share. The fair value was determined using the probability of a successful Business Combination of 2.25%, a volatility of 60.0%, a discount for lack or marketability of $1.04 and the value per shares as of the valuation date of $9.32 derived from an option pricing model for publicly traded warrants. Each Non-Redeeming Shareholder acquired from the Sponsor an indirect economic interest in such Founder Shares. The excess of the fair value of such Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, it was recognized by the Company as a capital contribution by the Sponsor to induce these Non-Redeeming Shareholders not to redeem the Non-Redeemed Shares, with a corresponding charge to additional paid-in capital to recognize the fair value of the Founder Shares subject to transfer as an offering cost.

v3.23.3
Class A Ordinary Shares Subject to Possible Redemption
9 Months Ended
Sep. 30, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]  
Class A Ordinary Shares Subject to Possible Redemption

Note 7 — Class A Ordinary Shares Subject to Possible Redemption

 

The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 3,593,271 and 30,000,000 Class A ordinary shares subject to possible redemption, respectively.

 

The Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:

 

Gross proceeds from Initial Public Offering  $300,000,000 
Less:     
Fair value of Public Warrants at issuance   (11,113,500)
Offering Costs allocated to Class A ordinary shares subject to possible redemption   (17,088,566)
Plus:     
Increase in redemption value of Class A ordinary shares subject to possible redemption   38,365,280 
Class A ordinary shares subject to possible redemption as of December 31, 2022   310,163,214 
Less:     
Redemption   (274,207,726)
Increase in redemption value of Class A ordinary shares subject to possible redemption   2,986,102 
Class A ordinary shares subject to possible redemption as of September 30, 2023  $38,941,590 
v3.23.3
Shareholders' Deficit
9 Months Ended
Sep. 30, 2023
Shareholders' Deficit [Abstract]  
Shareholders' Deficit

Note 8 — Shareholders’ Deficit

 

Preference shares—The Company is authorized to issue 5,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023, and December 31, 2022, there were no preference shares issued or outstanding.

 

Class A ordinary shares—The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023, and December 31, 2022, there were 4,915,271 and 31,322,000 Class A ordinary shares issued and outstanding, of which 3,593,271 and 30,000,000 shares were subject to possible redemption and have been classified as temporary equity, respectively (see Note 7).

 

Class B ordinary shares—The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.00009 per share. At July 2, 2021, there were 8,625,000 Class B ordinary shares issued and outstanding. Class B ordinary shares are subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that initial shareholders will collectively own approximately 25% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding the Private Placement Shares). On November 9, 2021, the Company effected a 1.1111111-for-1 stock split and a 379,500 Class B ordinary share stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which were subject to forfeiture if the over-allotment option were not exercised in full or in part by the underwriters. As a result of the stock split, the par value of Class B ordinary shares was lowered to $0.00009. On November 15, 2021, the underwriters partially exercised their over-allotment option resulting in 5,000 shares being forfeited and 10,000,000 Class B ordinary shares issued and outstanding. As of September 30, 2023, and December 31, 2022, there were 10,000,000 shares issued and outstanding.

 

Prior to the initial Business Combination, only holders of Class B ordinary shares will have the right to vote on the appointment of directors. In addition, in a vote to continue the company in a jurisdiction outside the Cayman Islands (which requires the approval of at least two thirds of the votes of all ordinary shares voted at a general meeting), holders of the Class B ordinary shares will have ten votes for every Class B ordinary share and holders of Class A ordinary shares will have one vote for every Class A ordinary share. Holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of Class B ordinary shares may remove a member of the board of directors for any reason. With respect to any other matter submitted to a vote of the shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of Class B and Class A ordinary shares will vote together as a single class, with each share entitling the holder to one vote.

 

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, approximately 25% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Units (and securities included in the units) issued to the Sponsor, its affiliates or any member of the management team in the Private Placement or upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

v3.23.3
Warrants
9 Months Ended
Sep. 30, 2023
Warrants [Abstract]  
Warrants

Note 9 — Warrants

 

As of September 30, 2023, and December 31, 2022, the Company had 15,000,000 Public Warrants and 661,000 Private Placement Warrants outstanding.

 

The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market value and the Newly Issued Price.

 

The warrants underlying the Private Placement Units (the “Private Placement Warrants”) are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

  in whole and not in part;

 

  at a price of $0.01 per warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption; and

 

  if, and only if, the Redemption Reference Price equals or exceeds $18.00 per share (as adjusted).

 

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Fair Value Measurements

Note 10 — Fair Value Measurements

 

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

 

September 30, 2023

 

Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $39,041,590   $
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $   $655,500   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $28,886 
Forward Purchase Agreement  $
   $
   $368,038 
Convertible note – related party  $
   $
   $525,824 

 

December 31, 2022

 

Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $310,263,214   $
      —
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $
   $900,000   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $39,660 
Forward Purchase Agreement  $
   $
   $641,567 
Convertible note – related party  $
   $
   $525,824 

 

Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period.

 

The Company values its investments held in money market accounts as Level 1 instruments, since they include investments in money market funds invested in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

 

The estimated fair value of Public Warrants for $10,500,000 was transferred from a Level 3 fair value measurement to Level 1 and Level 2 measurements when the Public Warrants were separately listed and traded in January 2022. The initial fair value of the Public Warrants and Private Placement Warrants was measured at fair value using a stochastic trinomial tree model, a Level 3 Measurement. On December 31, 2022 the Public Warrants were transferred to a Level 2 Measurement, due to limited traded volume. During January 2023, the Public warrants traded at a higher volume and were measured as a Level 1 Measurement on March 31, 2023. During September 2023, on or around period end, the Public Warrants were transferred to a Level 2 measurement, due to a limited trading volume.

 

The estimated fair value of the Private Placement Warrants is determined using Level 3 input during the IPO of the Company in November 2021. The Company used a stochastic trinomial tree model to value the Private Placement warrants, wherein input assumptions are related to expected flat volatility, expected life, risk-free rate and dividend yield. There have been no transfers to/from levels 1, 2 or 3 for Private Placement Warrants during the reporting period ending September 30, 2023 and year ended December 31, 2022.

 

The Company used an intrinsic value model to determine the fair value of the Convertible note at December 31, 2022. As of September 30, 2023 and December 31, 2022, the portion of the Sponsor Note carried under the fair value method is described as “Convertible Promissory Note – Related Party, Fair Value” on the accompanying condensed consolidated balance sheets with a balance of $525,824, respectively. The 2022 proceeds from principal on the Convertible Promissory Note – Related Party, Fair Value totaled $512,000, and were historically fair valued to the amount of $525,824, containing a $13,824 change in value recorded on the statement of operations for the year ended December 31, 2022. There were no changes in fair value or principle recorded during the period ended September 30, 2023.

During the period ended June 30, 2023, the Company has concluded that the fair value of the conversion feature on 2023 proceeds from principal, require bifurcation under ASC 815 and is considered de minimis. The underlying economics of the transaction are more accurately represented by recording this portion of the convertible debt agreement as a liability at par value given the de minimis value of the embedded conversion feature in this case.

 

The estimated fair value of the Forward Purchase Agreement was measured at fair value using a Monte Carlo simulation model, which was determined using Level 3 inputs. Inherent in the Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, expected Business Combination close date and probability of a successful transaction. The Company estimates the volatility based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. Any changes in these assumptions can change the valuation significantly.

 

For the three and nine months ended September 30, 2023, the Company recognized a gain of approximately $189,000 and $255,000, respectively, resulting from a change in the fair value of derivative liabilities, which represent changes in fair value of the Private Placement Warrants and the FPA, presented as change in fair value of derivative liabilities on the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2022, the Company recognized a gain of approximately $117,000 and $9.8 million, respectively.

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the derivative Private Placement warrant liabilities:

 

   September 30,
2023
   December 31,
2022
 
Exercise price  $11.50   $11.50 
Stock price  $10.80   $10.24 
Volatility   3.5%   1.5%
Term (years)   5    5 
Risk-free rate   2.00%   2.00%
Dividend yield   0.0%   0.0%

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the Forward Purchase Agreement derivative liabilities:

 

   September 30,
2023
   December 31,
2022
 
Probability of a Business Combination Close   1.00%   1.5%
Stock price as of Valuation Date  $10.80   $10.24 
Expected Stock price as of Business Combination Date  $11.45   $10.51 
Risk-Free Rate   4.74%   4.18%

 

The change in the fair value of derivative liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2023 and 2022 is summarized as follows:

 

Derivative warrant liabilities at December 31, 2022  $681,227 
Change in fair value of derivative liabilities   525,603 
Derivative warrant liabilities at March 31, 2023   1,206,830 
Change in fair value of derivative liabilities   (674,951)
Derivative warrant liabilities at June 30, 2023   531,879 
Change in fair value of derivative liabilities   (135,955)
Derivative warrant liabilities at September 30, 2023  $396,924 

 

Derivative warrant liabilities at December 31, 2021  $10,962,700 
Transfer of Public Warrants to Level 1   (10,500,000)
Change in fair value of derivative warrant liabilities   (198,300)
Derivative warrant liabilities at March 31, 2022   264,400 
Change in fair value of derivative warrant liabilities   (211,520)
Derivative warrant liabilities at June 30, 2022   52,880 
Change in fair value of derivative warrant liabilities   (4,957)
Derivative warrant liabilities at September 30, 2022  $47,923 

 

The change in the fair value of the convertible note—related party, measured utilizing Level 3 measurements for the three and nine months ended September 30, 2023, is summarized as follows:

 

Working capital loan – related party at December 31, 2022—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at March 31, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at June 30, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at September 30, 2023—Level 3 measurement  $525,824 
v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 11 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed consolidated financial statements were issued. Based on this review, the Company did not identify any subsequent events, other than below, that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

 

On October 27, 2023, the Company held the Second Shareholder Meeting at which the Company shareholders approved (i) the Second Extension Amendment Proposal, (ii) (the Redemption Limitation Amendment Proposal), and (iii) (the Founder Share Amendment Proposal. The Articles Amendment Proposals are described in more detail in BCSA’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 5, 2023. In connection with the Second Shareholder Meeting, the Sponsor entered into Non-Redemption Agreements with several unaffiliated third parties and agreed to transfer an aggregate of 304,712 ordinary shares of the Company to such parties in exchange for them agreeing not to redeem an aggregate of 2,031,411 public shares at the Second Shareholder Meeting.

 

In connection with the approval of the Founder Share Amendment Proposal, the sponsor of the Company, voluntarily elected to convert all 9,850,000 of its Founder Shares to Class A Shares, and the independent directors of BCSA voluntarily elected to convert all 150,000 of their Founder Shares to Class A Shares, in each case, on a one-for-one basis in accordance with the Memorandum and Articles of Association (such conversions collectively, the “Founder Share Conversion”). The Sponsor and the independent directors waived any right to receive funds from the trust account established by the Company in connection with its initial public offering with respect to the Class A Shares received upon such conversion and no additional amounts were deposited into the Trust Account in respect of any of those Class A Shares.

 

In connection with the vote to approve the Articles Amendment Proposals, holders of 1,481,477 Class A Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $16.2 million (approximately $10.91 per share) was removed from the Trust Account to redeem such shares. Upon payment of the redemption, and after giving effect to the Founder Share Conversion, BCSA has approximately 13,433,794 Class A Shares outstanding, including 2,111,794 Class A Shares having a right to request redemptions for a pro rata portion of the funds remaining in the Trust Account. 

 

On November 8, 2023, the Company delivered to Qenta written notice of its election to terminate the Business Combination Agreement pursuant to Section 7.1(h) thereof, and abandoned the Qenta Business Combination, primarily based on Qenta’s failure to (i) deliver the Closing Company Financial Statements (as defined in the Business Combination Agreement) by the applicable deadline and (ii) comply with the Financial Information Obligations specified in the First BCA Amendment. In connection with the Sponsor’s obligations in support of the Qenta Business Combination and Qenta’s failure to meet the Financial Information Obligations, Qenta delivered to the Sponsor 50 shares of Qenta common stock to reimburse the Sponsor and the Company for costs, expenses and other liabilities incurred in connection with the Business Combination Agreement.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023, or any future period.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 17, 2023.

Principles of Consolidation

Principles of Consolidation

The unaudited condensed consolidated financial statements of the Company include its wholly owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in the accompanying unaudited condensed consolidated financial statements is the determination of the fair value of derivative warrant liabilities. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2023 and December 31, 2022.

Investments Held in Trust Account

Investments Held in Trust Account

The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income earned on investments held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Convertible Promissory Note —Related Party, Fair Value Convertible Promissory Note —Related Party, Fair ValueThe Company entered into a convertible promissory note with its Sponsor on June 15, 2022. The Company has elected the fair value option to account for proceeds received during 2022. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Fair Value.” The primary reason for electing the fair value option in the 2022 proceeds is to provide better information on the financial liability amount given current market and economic conditions of the Company. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value recorded as change in the fair value of convertible note—related party on the accompanying unaudited condensed consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.
Convertible Promissory Note —Related Party, Par Value Convertible Promissory Note —Related Party, Par ValueThe Company has elected the bifurcated option to account for proceeds received during 2023 from the Convertible promissory notes with its Sponsor on June 2023. This amount is presented on the balance sheet as “Convertible Promissory Note —Related Party, Par Value.”The Company analyzed the Convertible Promissory Note – Related Party to assess if the fair value option was appropriate in 2023, due to the substantial premium which results in an offsetting entry to additional paid in capital and under the related party guidance which precludes the fair value option it was determined the fair value option was not appropriate. As such, the Company accounted for the Convertible Promissory Note – Related Party, Par Value, analyzing the conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments.The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as nonoperating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense.It was determined that the previous conversion option was de minimis, as such the Company has recorded the Convertible Promissory Note – Related Party at par value through the rest of the note’s use. 
Derivative Liabilities

Derivative Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants was estimated using a stochastic trinomial tree model. The determination of the fair value of the warrants may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

The Company determined the Forward Purchase Agreement (defined in Note 1) is a derivative instrument. Accordingly, the Company recognizes the instrument as an asset or liability at fair value and adjusts the instrument to fair value at each reporting period. Any changes in fair value are recognized on the Company’s unaudited condensed consolidated statements of operations. The estimated fair value of the Forward Purchase Agreement is measured at fair value utilizing a Monte Carlo simulation model.

Offering Costs Associated with the Initial Public Offering

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Class A Ordinary Shares Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. As part of the Private Placement, the Company issued 1,322,000 Class A ordinary shares to the Sponsor (“Private Placement Shares”). These Private Placement Shares will not be transferable, assignable or saleable until 30 days after the completion of the initial Business Combination, as such they are considered non-redeemable and presented as permanent equity in the Company’s condensed consolidated balance sheets. Excluding the Private Placement Shares, the Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 3,593,271 and 30,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed consolidated balance sheets, respectively.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in redemption value of Class A ordinary shares subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income per Ordinary Share

Net Income per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.

The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 15,661,000 Class A ordinary shares because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each period presented:

   For the Three Months Ended September 30,   For the Nine months Ended September 30, 
   2023   2022   2023   2022 
   Class A   Class B   Class A   Class B   Class A   Class B   Class A   Class B 
Basic and diluted net income per ordinary share:                                
Numerator:                                
Allocation of net income  $143,528   $292,005   $327,004   $104,401   $314,296   $357,789   $6,279,071   $2,004,684 
Denominator:                                        
Basic and diluted weighted average ordinary shares outstanding
   4,915,271    10,000,000    31,322,000    10,000,000    8,784,389    10,000,000    31,322,000    10,000,000 
Basic and diluted net income per ordinary share
  $0.03   $0.03   $0.01   $0.01   $0.04   $0.04   $0.20   $0.20 
Recent Accounting Standards

Recent Accounting Standards

In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its condensed consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

v3.23.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies [Abstract]  
Schedule of Basic and Diluted Net Income Per Ordinary Share The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each period presented:
   For the Three Months Ended September 30,   For the Nine months Ended September 30, 
   2023   2022   2023   2022 
   Class A   Class B   Class A   Class B   Class A   Class B   Class A   Class B 
Basic and diluted net income per ordinary share:                                
Numerator:                                
Allocation of net income  $143,528   $292,005   $327,004   $104,401   $314,296   $357,789   $6,279,071   $2,004,684 
Denominator:                                        
Basic and diluted weighted average ordinary shares outstanding
   4,915,271    10,000,000    31,322,000    10,000,000    8,784,389    10,000,000    31,322,000    10,000,000 
Basic and diluted net income per ordinary share
  $0.03   $0.03   $0.01   $0.01   $0.04   $0.04   $0.20   $0.20 
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Tables)
9 Months Ended
Sep. 30, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]  
Schedule of Subject to Possible Redemption Reflected on the Condensed Consolidated Balance Sheets The Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:
Gross proceeds from Initial Public Offering  $300,000,000 
Less:     
Fair value of Public Warrants at issuance   (11,113,500)
Offering Costs allocated to Class A ordinary shares subject to possible redemption   (17,088,566)
Plus:     
Increase in redemption value of Class A ordinary shares subject to possible redemption   38,365,280 
Class A ordinary shares subject to possible redemption as of December 31, 2022   310,163,214 
Less:     
Redemption   (274,207,726)
Increase in redemption value of Class A ordinary shares subject to possible redemption   2,986,102 
Class A ordinary shares subject to possible redemption as of September 30, 2023  $38,941,590 
v3.23.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:
Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $39,041,590   $
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $   $655,500   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $28,886 
Forward Purchase Agreement  $
   $
   $368,038 
Convertible note – related party  $
   $
   $525,824 
Description  Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:            
Investments held in Trust Account – Money market fund  $310,263,214   $
      —
   $
 
Liabilities:               
Derivative warrant liabilities—Public Warrants  $
   $900,000   $
 
Derivative warrant liabilities—Private Warrants  $
   $
   $39,660 
Forward Purchase Agreement  $
   $
   $641,567 
Convertible note – related party  $
   $
   $525,824 
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Derivative Private Placement Warrant Liabilities The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the derivative Private Placement warrant liabilities:
   September 30,
2023
   December 31,
2022
 
Exercise price  $11.50   $11.50 
Stock price  $10.80   $10.24 
Volatility   3.5%   1.5%
Term (years)   5    5 
Risk-free rate   2.00%   2.00%
Dividend yield   0.0%   0.0%
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Forward Purchase Agreement Derivative Liabilities The following table provides quantitative information regarding Level 3 fair value measurement inputs at their measurement dates for the Forward Purchase Agreement derivative liabilities:
   September 30,
2023
   December 31,
2022
 
Probability of a Business Combination Close   1.00%   1.5%
Stock price as of Valuation Date  $10.80   $10.24 
Expected Stock price as of Business Combination Date  $11.45   $10.51 
Risk-Free Rate   4.74%   4.18%
Schedule of Change in the Fair Value of Derivative Liabilities The change in the fair value of derivative liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2023 and 2022 is summarized as follows:
Derivative warrant liabilities at December 31, 2022  $681,227 
Change in fair value of derivative liabilities   525,603 
Derivative warrant liabilities at March 31, 2023   1,206,830 
Change in fair value of derivative liabilities   (674,951)
Derivative warrant liabilities at June 30, 2023   531,879 
Change in fair value of derivative liabilities   (135,955)
Derivative warrant liabilities at September 30, 2023  $396,924 
Derivative warrant liabilities at December 31, 2021  $10,962,700 
Transfer of Public Warrants to Level 1   (10,500,000)
Change in fair value of derivative warrant liabilities   (198,300)
Derivative warrant liabilities at March 31, 2022   264,400 
Change in fair value of derivative warrant liabilities   (211,520)
Derivative warrant liabilities at June 30, 2022   52,880 
Change in fair value of derivative warrant liabilities   (4,957)
Derivative warrant liabilities at September 30, 2022  $47,923 

 

Schedule of Fair Value of the Convertible Note Related Party The change in the fair value of the convertible note—related party, measured utilizing Level 3 measurements for the three and nine months ended September 30, 2023, is summarized as follows:
Working capital loan – related party at December 31, 2022—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at March 31, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at June 30, 2023—Level 3 measurement  $525,824 
Proceeds from the convertible note—related party   
 
Change in fair value of convertible note—related party—Level 3 measurement   
 
Working capital loan – related party at September 30, 2023—Level 3 measurement  $525,824 
v3.23.3
Organization and Business Operations (Details) - USD ($)
9 Months Ended
Nov. 15, 2021
Sep. 30, 2023
Aug. 24, 2023
Jun. 15, 2022
Organization and Business Operations (Details) [Line Items]        
Shares Issued Price Per Share (in Dollars per share) $ 10.2      
Transaction costs   $ 17,800,002    
Underwriting commissions   5,220,000    
Deferred underwriting commissions   11,280,000    
Other offering costs   $ 1,300,002    
Percentage fair market value balance in trust account   80.00%    
Proceeds from sale of units $ 306,000,000      
Stock price (in Dollars per share) $ 10.2 $ 1.04    
Outstanding ordinary shares, percentage   20.00%    
Public shares percentage   100.00%    
Dissolution expenses   $ 100,000    
Operating bank account   222,000    
Working capital deficit   6,800,000    
Convertible note payable   1,800,000    
Principal amount   1,767,244    
Borrowing capacity amount   $ 1,232,756    
IPO [Member]        
Organization and Business Operations (Details) [Line Items]        
Initial public offering units (in Shares) 30,000,000      
Shares Issued Price Per Share (in Dollars per share) $ 10      
Underwriting commissions $ 5,220,000      
Over-Allotment Option [Member]        
Organization and Business Operations (Details) [Line Items]        
Initial public offering units (in Shares) 3,900,000      
Private Placement [Member]        
Organization and Business Operations (Details) [Line Items]        
Initial public offering units (in Shares)   1,322,000    
Shares Issued Price Per Share (in Dollars per share)   $ 10    
Class A Ordinary Shares [Member]        
Organization and Business Operations (Details) [Line Items]        
Shares Issued Price Per Share (in Dollars per share) $ 10      
Ordinary share price per share (in Dollars per share) $ 11.5 11.5    
Stock price (in Dollars per share)   $ 12    
Aggregate percentage   15.00%    
Shares issued (in Shares)   1,481,477    
Class A Ordinary Shares [Member] | Sponsor [Member]        
Organization and Business Operations (Details) [Line Items]        
Shares issued (in Shares)     1,322,000  
Class A Ordinary Shares [Member] | IPO [Member]        
Organization and Business Operations (Details) [Line Items]        
Ordinary share price per share (in Dollars per share)   $ 0.0001    
Class A Ordinary Shares [Member] | Private Placement [Member]        
Organization and Business Operations (Details) [Line Items]        
Ordinary share price per share (in Dollars per share)   $ 10    
Class B Ordinary Shares [Member]        
Organization and Business Operations (Details) [Line Items]        
Shares of common stock (in Shares)   1    
Class B Ordinary Shares [Member] | Sponsor [Member]        
Organization and Business Operations (Details) [Line Items]        
Shares issued (in Shares)     3,178,000  
Blockchain Coinvestors Acquisition Corp. [Member]        
Organization and Business Operations (Details) [Line Items]        
Ownership percentage   50.00%    
Sponsor [Member]        
Organization and Business Operations (Details) [Line Items]        
Payments from sponsor   $ 25,000    
Unsecured promissory note   $ 131,517    
Sponsor [Member] | Minimum [Member]        
Organization and Business Operations (Details) [Line Items]        
Principal amount       $ 1,500,000
Sponsor [Member] | Maximum [Member]        
Organization and Business Operations (Details) [Line Items]        
Principal amount       $ 3,000,000
Sponsor [Member] | Class A Ordinary Shares [Member] | Private Placement [Member]        
Organization and Business Operations (Details) [Line Items]        
Initial public offering units (in Shares)   1,322,000    
Business Combination [Member]        
Organization and Business Operations (Details) [Line Items]        
Public shares percentage   100.00%    
v3.23.3
Significant Accounting Policies (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Significant Accounting Policies (Details) [Line Items]    
Cash insured with federal insurance (in Dollars) $ 250,000  
Purchase an aggregate shares 15,661,000  
Class A Ordinary Shares [Member]    
Significant Accounting Policies (Details) [Line Items]    
Share issued 1,322,000  
Temporary equity, shares outstanding 3,593,271 30,000,000
v3.23.3
Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income Per Ordinary Share - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A [Member]        
Numerator:        
Allocation of net income $ 143,528 $ 327,004 $ 314,296 $ 6,279,071
Denominator:        
Basic weighted average ordinary shares outstanding 4,915,271 31,322,000 8,784,389 31,322,000
Basic net income per ordinary share $ 0.03 $ 0.01 $ 0.04 $ 0.2
Class B [Member]        
Numerator:        
Allocation of net income $ 292,005 $ 104,401 $ 357,789 $ 2,004,684
Denominator:        
Basic weighted average ordinary shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
Basic net income per ordinary share $ 0.03 $ 0.01 $ 0.04 $ 0.2
v3.23.3
Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income Per Ordinary Share (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A [Member]        
Schedule of Basic and Diluted Net Income (loss) Per Share [Line Items]        
Diluted weighted average ordinary shares outstanding 4,915,271 31,322,000 8,784,389 31,322,000
Diluted net income per ordinary share $ 0.03 $ 0.01 $ 0.04 $ 0.20
Class B [Member]        
Schedule of Basic and Diluted Net Income (loss) Per Share [Line Items]        
Diluted weighted average ordinary shares outstanding 10,000,000 10,000,000 10,000,000 10,000,000
Diluted net income per ordinary share $ 0.03 $ 0.01 $ 0.04 $ 0.20
v3.23.3
Initial Public Offering (Details)
Nov. 15, 2021
USD ($)
$ / shares
shares
Initial Public Offering (Details) [Line Items]  
Sale of stock issue price per share $ 10.2
Payments to acquire trust preferred investment (in Dollars) | $ $ 306,000,000
IPO [Member]  
Initial Public Offering (Details) [Line Items]  
Stock issued during period shares new issues (in Shares) | shares 30,000,000
Sale of stock issue price per share $ 10
Over-Allotment Option [Member]  
Initial Public Offering (Details) [Line Items]  
Stock issued during period shares new issues (in Shares) | shares 3,900,000
Class A Ordinary Shares [Member]  
Initial Public Offering (Details) [Line Items]  
Sale of stock issue price per share $ 10
Public Warrants [Member] | Class A Ordinary Shares [Member]  
Initial Public Offering (Details) [Line Items]  
Class of warrant or right, exercise price of warrants or rights $ 11.5
v3.23.3
Private placement (Details) - Class A Ordinary Shares [Member] - USD ($)
9 Months Ended
Sep. 30, 2023
Nov. 15, 2021
Private placement (Details) [Line Items]    
Class of warrants exercise price per share $ 11.5 $ 11.5
Private Placement [Member]    
Private placement (Details) [Line Items]    
Class of warrants exercise price per share $ 10  
Aggregate, in a private placement (in Dollars) $ 13,220,000  
Sponsor [Member] | Private Placement [Member]    
Private placement (Details) [Line Items]    
Stock issued during period value new issues (in Shares) 1,322,000  
v3.23.3
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 15, 2021
Nov. 09, 2021
Nov. 09, 2021
Jul. 02, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 15, 2022
Related Party Transactions (Details) [Line Items]                    
Sponsor paid       $ 25,000     $ 15,000      
Share price (in Dollars per share) $ 10.2                  
Issued and outstanding (in Shares)   10,005,000 10,005,000   10,000,000   10,000,000   10,000,000  
Shares subject to forfeiture (in Shares)   1,305,000                
Shares issued (in Shares)   1,300,000 1,300,000              
Founder shares year             1 year      
Price per share (in Dollars per share) $ 10.2       $ 1.04   $ 1.04      
Aggregate amount $ 131,517                  
Working capital loans             $ 1,500,000      
Company issued                   $ 1,500,000
Principal amount         $ 1,767,244   1,767,244      
Principal amount         1,767,244   1,767,244      
Borrowing capacity amount         1,232,756   1,232,756      
Note payable related party         $ 525,824   525,824   $ 525,824  
Accrued expenses             $ 14,900   $ 106,000  
Founder Shares [Member]                    
Related Party Transactions (Details) [Line Items]                    
Founder shares, percentage     25.00%              
Promissory Note [Member]                    
Related Party Transactions (Details) [Line Items]                    
Sponsor paid       $ 300,000            
Sponsor [Member]                    
Related Party Transactions (Details) [Line Items]                    
Price per unit (in Dollars per share)                   $ 10
Over-Allotment Option [Member]                    
Related Party Transactions (Details) [Line Items]                    
Shares subject to forfeiture (in Shares)     1,305,000              
Founder shares forfeited (in Shares) 15,000   5,000              
Private Placement [Member]                    
Related Party Transactions (Details) [Line Items]                    
Share price (in Dollars per share)         $ 10   $ 10      
Price per unit (in Dollars per share)         $ 10   $ 10      
Class B Ordinary Shares [Member] | Founder Shares [Member]                    
Related Party Transactions (Details) [Line Items]                    
Consideration for issuance (in Shares)       8,625,000            
Class B Ordinary Shares [Member] | Over-Allotment Option [Member]                    
Related Party Transactions (Details) [Line Items]                    
Founder shares forfeited (in Shares) 5,000                  
Class A Ordinary Shares [Member]                    
Related Party Transactions (Details) [Line Items]                    
Share price (in Dollars per share) $ 10                  
Shares issued (in Shares)         3,593,271   3,593,271   30,000,000  
Price per share (in Dollars per share)         $ 12   $ 12      
Convertible Promissory Note [Member]                    
Related Party Transactions (Details) [Line Items]                    
Related party par value accompanying statement                 $ 0  
Related Party [Member]                    
Related Party Transactions (Details) [Line Items]                    
General and administrative expenses         $ 28,671 $ 45,000 $ 107,490 $ 135,000    
Sponsor [Member]                    
Related Party Transactions (Details) [Line Items]                    
Share price (in Dollars per share)       $ 0.003            
Principal amount                   $ 3,000,000
Fair value totaled                 512,000  
Historically fair valued amount                 525,824  
Change in fair value recorded amount                 13,824  
Related party par value accompanying statement         $ 1,241,420   $ 1,241,420   $ 1,241,420  
v3.23.3
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 9 Months Ended
Jan. 31, 2023
Nov. 15, 2021
Nov. 09, 2021
Oct. 27, 2023
Sep. 30, 2023
Commitments and Contingencies (Details) [Line Items]          
Underwriting commission         $ 5,220,000
Deferred underwriting commissions         $ 11,280,000
Minimum percentage of new common stock on post combination         9.90%
Amount for purchase of additional shares         $ 500,000
Maturity date of forward purchase agreement         36 months
Minimum break up fee agreed to pay to the FPA seller         $ 75,000
Percentage of share redemptions         80.00%
Funds in trust account         $ 16,200,000
Price per share   $ 10.2     $ 1.04
Merger advisory services fee         $ 6,200,000
Investment banking service, fee $ 1,250,000        
Founder shares         739,286
Aggregate fair value of founder shares         739,286
Redemption price         $ 155,250
Volatility rate         60.00%
Valuation per share         $ 9.32
Cantor Fitzgerald [Member]          
Commitments and Contingencies (Details) [Line Items]          
Deferred underwriting fee         $ 3,948,000
New Qenta Common Stock [Member]          
Commitments and Contingencies (Details) [Line Items]          
Share price         $ 1.75
Over-Allotment Option [Member]          
Commitments and Contingencies (Details) [Line Items]          
Stock issued during period shares   3,900,000      
Forfeited shares   15,000 5,000    
Initial Public Offering [Member]          
Commitments and Contingencies (Details) [Line Items]          
Stock issued during period shares   30,000,000      
Underwriting commission per unit   $ 0.2      
Underwriting commission   $ 5,220,000      
Private Placement Units [Member]          
Commitments and Contingencies (Details) [Line Items]          
Stock issued during period shares         1,322,000
Sponsor [Member]          
Commitments and Contingencies (Details) [Line Items]          
Converted shares         9,850,000
Units [Member] | Over-Allotment Option [Member] | Underwriter Commitment To Cover Over Allotments [Member]          
Commitments and Contingencies (Details) [Line Items]          
Stock issued during period shares         3,915,000
Class A Ordinary Shares [Member]          
Commitments and Contingencies (Details) [Line Items]          
Purchased shares         500,000
Converted shares         150,000
Exercised shares         1,481,477
Price per share         $ 12
Shares outstanding         13,433,794
Redemption shares         2,111,794
Class A ordinary shares subject to possible redemption [Member]          
Commitments and Contingencies (Details) [Line Items]          
Class A ordinary shares subject to possible redemption [Member]         26,406,729
Redemption price         $ 10.38
Redemption amount         $ 274,200,000
Redemption amount removed from trust account         $ 274,200,000
Trust account to redeem shares         4,915,271
Redemption amount remained in trust account         $ 37,300,000
Class A ordinary shares subject to possible redemption [Member] | Private Placement Units [Member]          
Commitments and Contingencies (Details) [Line Items]          
Trust account to redeem shares         1,322,000
Non-redemption Agreements [Member]          
Commitments and Contingencies (Details) [Line Items]          
Redemption price         $ 0.21
Subsequent Event [Member]          
Commitments and Contingencies (Details) [Line Items]          
Net tangible asset       $ 5,000,001  
Funds in trust account       $ 16,200,000  
Price per share       $ 10.91  
Subsequent Event [Member] | Sponsor [Member]          
Commitments and Contingencies (Details) [Line Items]          
Converted shares       9,850,000  
Subsequent Event [Member] | Class A Ordinary Shares [Member]          
Commitments and Contingencies (Details) [Line Items]          
Class A ordinary shares subject to possible redemption [Member]       1,481,477  
Converted shares       150,000  
Redemption shares       2,111,794  
Forward Purchase Agreement [Member]          
Commitments and Contingencies (Details) [Line Items]          
Number of subject shares         12,000,000
Percentage of shortfall amount         10.00%
Purchasing shares under the agreement         $ 350,000
Forward Purchase Agreement [Member] | New Qenta Common Stock [Member]          
Commitments and Contingencies (Details) [Line Items]          
Share price         $ 1.75
Trustee’s [Member]          
Commitments and Contingencies (Details) [Line Items]          
Price per share         $ 10.91
Business Combination [Member]          
Commitments and Contingencies (Details) [Line Items]          
Deferred underwriting fee         $ 7,896,000
Percentage of bussiness combination         2.25%
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A Ordinary Shares [Member] - $ / shares
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Class A Ordinary Shares Subject to Possible Redemption [Line Items]    
Authorized shares 500,000,000  
Temporary equity, par or stated value per share (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, vote one  
Ordinary shares subject to possible redemption 3,593,271 30,000,000
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Details) - Schedule of Subject to Possible Redemption Reflected on the Condensed Consolidated Balance Sheets - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Temporary Equity [Line Items]    
Gross proceeds from Initial Public Offering   $ 300,000,000
Less:    
Fair value of Public Warrants at issuance   (11,113,500)
Offering Costs allocated to Class A ordinary shares subject to possible redemption   (17,088,566)
Plus:    
Redemption $ (274,207,726)  
Increase in redemption value of Class A ordinary shares subject to possible redemption 2,986,102 38,365,280
Class A Ordinary Shares [Member]    
Plus:    
Class A ordinary shares subject to possible redemption $ 38,941,590 $ 310,163,214
v3.23.3
Shareholders' Deficit (Details) - $ / shares
9 Months Ended
Nov. 15, 2021
Nov. 09, 2021
Nov. 09, 2021
Jul. 02, 2021
Sep. 30, 2023
Dec. 31, 2022
Shareholders' Deficit (Details) [Line Items]            
Preference shares authorized         5,000,000 5,000,000
Preference shares issued        
Preference shares outstanding        
Common stock, shares issued         4,915,271 31,322,000
Common stock, shares outstanding         4,915,271 31,322,000
Ordinary shares subject to possible redemption, shares at redemption value   1,300,000 1,300,000      
Shares subject to forfeiture   1,305,000        
Shares issued         10,000,000 10,000,000
Shares outstanding   10,005,000 10,005,000   10,000,000 10,000,000
Stock conversion percentage threshold         25.00%  
Over-Allotment Option [Member]            
Shareholders' Deficit (Details) [Line Items]            
Shares subject to forfeiture     1,305,000      
Forfeited shares 15,000   5,000      
Class A Ordinary Shares [Member]            
Shareholders' Deficit (Details) [Line Items]            
Common stock, shares authorized         500,000,000 500,000,000
Common stock, par value (in Dollars per share)         $ 0.0001 $ 0.0001
Common stock, voting rights         one  
Common stock, shares issued         1,322,000 1,322,000
Common stock, shares outstanding         1,322,000 1,322,000
Ordinary shares subject to possible redemption, shares at redemption value         3,593,271 30,000,000
Class A Ordinary Shares [Member] | Common Stock [Member]            
Shareholders' Deficit (Details) [Line Items]            
Common stock, par value (in Dollars per share)         $ 0.0001  
Class B Ordinary Shares [Member]            
Shareholders' Deficit (Details) [Line Items]            
Common stock, shares authorized         50,000,000 50,000,000
Common stock, par value (in Dollars per share)   $ 0.00009 $ 0.00009   $ 0.00009 $ 0.00009
Common stock, shares issued 10,000,000 10,005,000 10,005,000 8,625,000 10,000,000 10,000,000
Common stock, shares outstanding 10,000,000 10,005,000 10,005,000 8,625,000 10,000,000 10,000,000
Dividend share   379,500        
Class B Ordinary Shares [Member] | Over-Allotment Option [Member]            
Shareholders' Deficit (Details) [Line Items]            
Percentage of common stock issued and outstanding       25.00%    
Forfeited shares 5,000          
Class B Ordinary Shares [Member] | Common Stock [Member]            
Shareholders' Deficit (Details) [Line Items]            
Common stock, par value (in Dollars per share)         $ 0.00009  
v3.23.3
Warrants (Details) - $ / shares
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Nov. 15, 2021
Warrants (Details) [Line Items]      
Exercisable price $ 11.5    
Issue price per ordinary share $ 1.04   $ 10.2
Public Warrants [Member]      
Warrants (Details) [Line Items]      
Warrants outstanding (in Shares) 15,000,000 15,000,000  
Issue price per ordinary share $ 9.2    
Aggregate gross proceeds percent 60.00%    
Trading days 20 days    
Volume weighted average trading price of shares $ 9.2    
Exercise price of warrants as a percentage of newly issued share price 115.00%    
Redemption trigger price per share $ 18    
Private Placement [Member]      
Warrants (Details) [Line Items]      
Warrants outstanding (in Shares) 661,000 661,000  
Private Placement Warrants [Member]      
Warrants (Details) [Line Items]      
Price per warrant $ 0.01    
Prior written notice of redemption 30 days    
Newly adjusted issue share price $ 18    
Class A Ordinary Shares [Member]      
Warrants (Details) [Line Items]      
Issue price per ordinary share 12    
Price per warrant $ 11.5   $ 11.5
Class A Ordinary Shares [Member] | Public Warrants [Member]      
Warrants (Details) [Line Items]      
Exercise price of warrants as a percentage of newly issued share price 180.00%    
Class A Ordinary Shares [Member] | Private Placement [Member]      
Warrants (Details) [Line Items]      
Price per warrant $ 10    
v3.23.3
Fair Value Measurements (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 30, 2023
Mar. 31, 2023
Fair Value Measurements (Details) [Line Items]              
Consolidated balance sheets $ 525,824   $ 525,824   $ 525,824    
Related party, fair value         512,000    
Fair value amount         525,824    
Change in value recorded         13,824    
Recognized loss 189,000 $ 117,000 255,000 $ 9.8      
Level 3 [Member]              
Fair Value Measurements (Details) [Line Items]              
Consolidated balance sheets $ 525,824   525,824   $ 525,824 $ 525,824 $ 525,824
Level 3 [Member] | Public Warrants [Member] | Fair Value, Recurring [Member]              
Fair Value Measurements (Details) [Line Items]              
Estimated fair value of public warrants     $ 10,500,000        
v3.23.3
Fair Value Measurements (Details) - Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis - Fair Value, Recurring [Member] - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Investments held in Trust Account – Money market fund $ 39,041,590 $ 310,263,214
Liabilities:    
Convertible note – related party
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities  
Fair Value, Inputs, Level 1 [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Fair Value, Inputs, Level 1 [Member] | Forward Purchase Agreement [Member]    
Liabilities:    
Forward Purchase Agreement
Fair Value, Inputs, Level 2 [Member]    
Assets:    
Investments held in Trust Account – Money market fund
Liabilities:    
Convertible note – related party
Fair Value, Inputs, Level 2 [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 655,500 900,000
Fair Value, Inputs, Level 2 [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Fair Value, Inputs, Level 2 [Member] | Forward Purchase Agreement [Member]    
Liabilities:    
Forward Purchase Agreement
Fair Value, Inputs, Level 3 [Member]    
Assets:    
Investments held in Trust Account – Money market fund
Liabilities:    
Convertible note – related party 525,824 525,824
Fair Value, Inputs, Level 3 [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Fair Value, Inputs, Level 3 [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 28,886 39,660
Fair Value, Inputs, Level 3 [Member] | Forward Purchase Agreement [Member]    
Liabilities:    
Forward Purchase Agreement $ 368,038 $ 641,567
v3.23.3
Fair Value Measurements (Details) - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Derivative Private Placement Warrant Liabilities - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Term (years) 5 years 5 years
Measurement Input, Exercise Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Exercise price (in Dollars per share) $ 11.5 $ 11.5
Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Stock price (in Dollars per share) $ 10.8 $ 10.24
Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Volatility 3.50% 1.50%
Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Risk-free rate 2.00% 2.00%
Measurement Input, Expected Dividend Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Dividend yield 0.00% 0.00%
v3.23.3
Fair Value Measurements (Details) - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Forward Purchase Agreement Derivative Liabilities - Fair Value, Inputs, Level 3 [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]    
Probability of a Business Combination Close 1.00% 1.50%
Stock price as of Valuation Date $ 10.8 $ 10.24
Expected Stock price as of Business Combination Date $ 11.45 $ 10.51
Risk-Free Rate 4.74% 4.18%
v3.23.3
Fair Value Measurements (Details) - Schedule of Change in the Fair Value of Derivative Liabilities - USD ($)
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Schedule of Change in the Fair Value of Derivative Liabilities [Abstract]            
Derivative warrant liabilities $ 531,879 $ 1,206,830 $ 681,227 $ 52,880 $ 264,400 $ 10,962,700
Transfer of Public Warrants to Level 1           (10,500,000)
Derivative warrant liabilities 396,924 531,879 1,206,830 47,923 52,880 264,400
Change in fair value of derivative warrant liabilities $ (135,955) $ (674,951) $ 525,603 $ (4,957) $ (211,520) $ (198,300)
v3.23.3
Fair Value Measurements (Details) - Schedule of Fair Value of the Convertible Note Related Party - Fair Value, Inputs, Level 3 [Member] - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Fair Value Measurements (Details) - Schedule of Fair Value of the Convertible Note Related Party [Line Items]        
Working capital loan – related party beginning $ 525,824 $ 525,824 $ 525,824 $ 525,824
Working capital loan – related party ending 525,824 525,824 525,824 $ 525,824
Proceeds from the convertible note—related party  
Change in fair value of convertible note—related party—Level 3 measurement  
v3.23.3
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 9 Months Ended
Nov. 08, 2023
Oct. 27, 2023
Sep. 30, 2023
Nov. 15, 2021
Subsequent Events (Details) [Line Items]        
Aggregate Shares   304,712    
Public shares   2,031,411    
Funds in trust account (in Dollars)     $ 16.2  
Redeemed price per share (in Dollars per share)     $ 1.04 $ 10.2
Sponsor [Member]        
Subsequent Events (Details) [Line Items]        
Converted shares     9,850,000  
Class A Ordinary Shares [Member]        
Subsequent Events (Details) [Line Items]        
Converted shares     150,000  
Redeemed price per share (in Dollars per share)     $ 12  
Redemption shares     2,111,794  
Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Funds in trust account (in Dollars)   $ 16.2    
Redeemed price per share (in Dollars per share)   $ 10.91    
Sponsor shares 50      
Subsequent Event [Member] | Sponsor [Member]        
Subsequent Events (Details) [Line Items]        
Converted shares   9,850,000    
Subsequent Event [Member] | Class A Ordinary Shares [Member]        
Subsequent Events (Details) [Line Items]        
Converted shares   150,000    
Shares exercised   1,481,477    
Shares outstanding   13,433,794    
Redemption shares   2,111,794    

1 Year Blockchain Coinvestors A... Chart

1 Year Blockchain Coinvestors A... Chart

1 Month Blockchain Coinvestors A... Chart

1 Month Blockchain Coinvestors A... Chart

Your Recent History

Delayed Upgrade Clock